{"meta":{"page":1,"per_page":50,"max_per_page":100,"total":199,"total_is_capped":false,"direct_labels_cover":0,"predictions_cover":199,"direct_label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline (scores rank; they never assert a category)","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12","author_layer_release":"2026-06-26"},"query_hash":"4bfe58bd6a87","filters":{"venue":"Journal of Medical Economics"}},"results":[{"id":"W4200054040","doi":"10.1080/13696998.2021.2007691","title":"The Global South political economy of health financing and spending landscape – history and presence","year":2021,"lang":"en","type":"review","venue":"Journal of Medical Economics","topic":"Global Public Health Policies and Epidemiology","field":"Business, Management and Accounting","cited_by":120,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto","funders":"Science Fund of the Republic of Serbia; Ministarstvo Prosvete, Nauke i Tehnološkog Razvoja","keywords":"Politics; Multinational corporation; Economic growth; East Asia; Development economics; Medicine; China; Business; Economics; Political science; Finance","authors":[{"name":"Mihajlo Jakovljević","is_ca":false},{"name":"Yansui Liu","is_ca":false},{"name":"Arcadio A. Cerda","is_ca":false},{"name":"Marta Simonyan","is_ca":false},{"name":"Tiago Correia","is_ca":false},{"name":"Richard M. Mariita","is_ca":false},{"name":"Ajantha Sisira Kumara","is_ca":false},{"name":"Leidy Y. García","is_ca":false},{"name":"K Krstić","is_ca":false},{"name":"Romanus Osabohien","is_ca":false},{"name":"Trần Khánh Toàn","is_ca":false},{"name":"Chiranjivi Adhikari","is_ca":false},{"name":"Nguyễn Thị Kim Chúc","is_ca":false},{"name":"Resham B. Khatri","is_ca":false},{"name":"Vijay Kumar Chattu","is_ca":true},{"name":"Liang WANG","is_ca":false},{"name":"Tissa Wijeratne","is_ca":false},{"name":"Eugène Kouassi","is_ca":false},{"name":"Habib Nawaz Khan","is_ca":false},{"name":"Mirjana Varjačić","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.07373820326831175,"gpt":0.3464244995850857,"spread":0.2726862963167739,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005042354,0.0001939541,0.001807624,0.00009858264,0.0001136353,0.000080987,0.0003869408,0.00025735,0.00004378076],"category_scores_gemma":[0.002159394,0.0001301407,0.000214657,0.00006731967,0.000255896,0.0002197052,0.000375156,0.0005025553,0.000002607256],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003826114,"about_ca_system_score_gemma":0.001585014,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003479551,"about_ca_topic_score_gemma":0.00003326397,"domain_scores_codex":[0.9973103,0.0001159126,0.001759408,0.0001890857,0.0001265983,0.000498743],"domain_scores_gemma":[0.9967109,0.0007133447,0.00219285,0.0001518818,0.0000631361,0.0001679131],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000003430802,0.00001318783,0.0002687953,0.005828313,0.00008029408,0.000009081212,0.00001305682,0.000004203464,6.926686e-11,0.5853472,0.03686152,0.3715709],"study_design_scores_gemma":[0.0001887905,0.00001763969,0.00005713814,0.002360745,0.00007501513,0.0002071359,0.0002214873,0.001311503,2.425384e-10,0.003608668,0.9918582,0.00009368473],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000181438,0.9706395,0.00006130191,0.02440679,0.001040432,0.0001096793,0.000005788959,0.000003483125,0.003551575],"genre_scores_gemma":[0.0003481902,0.9916012,0.0000568855,0.006420781,0.001547238,0.000001768659,0.00000426246,0.00001191658,0.000007779854],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9549966,"threshold_uncertainty_score":0.5306982,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2906443950","doi":"10.1080/13696998.2019.1590843","title":"The burden of osteoporosis in four Latin American countries: Brazil, Mexico, Colombia, and Argentina","year":2019,"lang":"en","type":"review","venue":"Journal of Medical Economics","topic":"Bone health and osteoporosis research","field":"Medicine","cited_by":119,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Amgen (Canada)","funders":"","keywords":"Medicine; Latin Americans; Osteoporosis; Environmental health; Medical prescription; Indirect costs; Business","authors":[{"name":"Rima Aziziyeh","is_ca":true},{"name":"Mo Amin","is_ca":true},{"name":"Mohdhar Habib","is_ca":false},{"name":"J Garcia Perlaza","is_ca":false},{"name":"Kirk Szafranski","is_ca":false},{"name":"Rebecca K. McTavish","is_ca":false},{"name":"Tim Disher","is_ca":false},{"name":"Ana Lüdke","is_ca":false},{"name":"Chris Cameron","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04913371673496721,"gpt":0.3803805302742925,"spread":0.3312468135393253,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004636731,0.0002717777,0.003225868,0.0003360038,0.00006440856,0.00004457791,0.0005073888,0.0004496035,0.0001787701],"category_scores_gemma":[0.001841685,0.0001720942,0.0004417894,0.0002398852,0.0006094011,0.00006511256,0.0001710052,0.001728623,0.00002310243],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003525217,"about_ca_system_score_gemma":0.005270837,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003846714,"about_ca_topic_score_gemma":0.000169362,"domain_scores_codex":[0.9956701,0.0002623855,0.002553104,0.0002421294,0.0007842004,0.0004880204],"domain_scores_gemma":[0.9941621,0.002203719,0.002328487,0.000349487,0.0001980488,0.0007581836],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002028025,0.00006509114,0.001022705,0.01075446,0.0002348518,0.00006704447,0.0001806083,0.000001503591,9.882673e-8,0.0001038652,0.005040048,0.9823269],"study_design_scores_gemma":[0.00157338,0.0008747772,0.0004582663,0.008822126,0.0003216241,0.000461022,0.0004173137,0.000169692,5.750538e-7,0.00002757204,0.9867419,0.0001317644],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.01769116,0.971174,0.000002180577,0.009639946,0.0004556139,0.0007413703,0.00003259797,0.000003182972,0.0002599241],"genre_scores_gemma":[0.0004841657,0.9980843,0.0001063624,0.0004474691,0.000515041,0.00001126421,0.000007373333,0.00004339441,0.0003006426],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9821951,"threshold_uncertainty_score":0.9350239,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2016112560","doi":"10.3111/13696998.2014.1003644","title":"Brain metastases in patients with ALK+ non-small cell lung cancer: clinical symptoms, treatment patterns and economic burden","year":2015,"lang":"en","type":"article","venue":"Journal of Medical Economics","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":101,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Crizotinib; Medicine; Lung cancer; Anaplastic lymphoma kinase; Internal medicine; Medical diagnosis; Oncology; ALK inhibitor; Brain metastasis; Ceritinib; Cancer; Metastasis; Radiology","authors":[{"name":"Annie Guérin","is_ca":true},{"name":"Medha Sasané","is_ca":false},{"name":"Jie Zhang","is_ca":false},{"name":"Kenneth W. Culver","is_ca":false},{"name":"Katherine Dea","is_ca":true},{"name":"Roy Nitulescu","is_ca":true},{"name":"Eric Q. Wu","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01814210425179501,"gpt":0.3340671243455227,"spread":0.3159250200937276,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005298746,0.0001613972,0.000616795,0.0001191054,0.00002066064,0.00002558808,0.00009926304,0.000115262,0.000106885],"category_scores_gemma":[0.00004730593,0.0001076637,0.00009783995,0.00002518551,0.00006275607,0.0001148414,0.00003044075,0.0002127551,0.000003749085],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008806575,"about_ca_system_score_gemma":0.001890419,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001212416,"about_ca_topic_score_gemma":0.001137362,"domain_scores_codex":[0.9986656,0.00005253018,0.0007442645,0.0001914816,0.0001552372,0.0001908505],"domain_scores_gemma":[0.9985475,0.0001670647,0.0003822611,0.0001351686,0.00006280092,0.000705198],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0003998786,0.0004555381,0.9668574,0.0000278635,0.0005515439,0.00007463369,0.0004346624,0.0003192996,7.785035e-8,0.00001339,0.001305964,0.02955973],"study_design_scores_gemma":[0.072584,0.006961822,0.8871367,0.0006170149,0.001717357,0.0001222985,0.0007531381,0.004795046,0.00002683712,0.0000364246,0.02492338,0.0003259894],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.992826,0.000574865,0.00005125031,0.005574908,0.0004022135,0.0002965828,0.0000655646,0.00000387099,0.000204767],"genre_scores_gemma":[0.9959272,0.002177256,0.0003932152,0.0007776463,0.000551875,0.00001383244,0.0000276493,0.00002346708,0.0001078961],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.07972073,"threshold_uncertainty_score":0.4390396,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2071344217","doi":"10.3111/13696998.2011.653726","title":"Satisfaction with botulinum toxin treatment: a cross-sectional survey of patients with cervical dystonia","year":2011,"lang":"en","type":"article","venue":"Journal of Medical Economics","topic":"Botulinum Toxin and Related Neurological Disorders","field":"Medicine","cited_by":99,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"Merz Pharmaceuticals","keywords":"Medicine; Cervical dystonia; Botulinum toxin; Patient satisfaction; Cross-sectional study; Quality of life (healthcare); Adverse effect; Physical therapy; Visual analogue scale; Internal medicine; Anesthesia; Surgery","authors":[{"name":"Kapil D. Sethi","is_ca":false},{"name":"Ramon L. Rodriguez","is_ca":false},{"name":"Babajide Olayinka","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03516939767736518,"gpt":0.2643901803924858,"spread":0.2292207827151206,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004333538,0.000158195,0.0004923579,0.0000988937,0.00003998991,0.00001028114,0.0001162079,0.0003304446,0.001099702],"category_scores_gemma":[0.0001441001,0.00008742704,0.0001172971,0.0001052789,0.0002879368,0.0001096728,0.00001802852,0.0004736505,0.000009207477],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001047168,"about_ca_system_score_gemma":0.0004094196,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002268453,"about_ca_topic_score_gemma":0.0003836548,"domain_scores_codex":[0.9984536,0.00007848494,0.0007069201,0.0001768559,0.000397632,0.0001865205],"domain_scores_gemma":[0.9985741,0.0001436051,0.0005036559,0.0001343347,0.0002473422,0.0003970104],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.006366101,0.0008332961,0.9894052,0.00001645505,0.0003279009,0.0000520407,0.00006745823,0.00004804011,0.000002576698,0.00005770998,0.00002231027,0.002800897],"study_design_scores_gemma":[0.008514037,0.006598176,0.9839581,0.00003812981,0.00007636485,0.000237451,0.00001174939,0.0002100707,0.00004556365,0.00007356137,0.0001461425,0.00009065524],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9987499,0.00005337016,0.0001774087,0.0002625811,0.0002233662,0.0001418417,0.00002048474,0.000008563566,0.0003625004],"genre_scores_gemma":[0.9986541,0.0004207031,0.0004603367,0.0003300812,0.00006744517,0.000001726202,0.00001323777,0.00001895649,0.00003341501],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005764879,"threshold_uncertainty_score":0.9998134,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2132266888","doi":"10.3111/13696998.2013.851082","title":"Prevalence and impact of constipation and bowel dysfunction induced by strong opioids: a cross-sectional survey of 520 patients with cancer pain: DYONISOS study","year":2013,"lang":"en","type":"article","venue":"Journal of Medical Economics","topic":"Gastrointestinal motility and disorders","field":"Medicine","cited_by":87,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Medicine; Constipation; Cross-sectional study; Internal medicine; Cancer; Colorectal cancer; Physical therapy; Pathology","authors":[{"name":"Laurent Abramowitz","is_ca":false},{"name":"Nicolas Béziaud","is_ca":false},{"name":"L. Labrèze","is_ca":false},{"name":"V. Giardina","is_ca":false},{"name":"Sébastien Causse","is_ca":false},{"name":"B. Chuberre","is_ca":false},{"name":"François‐André Allaert","is_ca":false},{"name":"Serge Perrot","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02279694631245742,"gpt":0.2994614495204641,"spread":0.2766645032080066,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001146224,0.00009348895,0.000296214,0.00006892636,0.00002727934,0.00001822969,0.00005477286,0.00007289011,0.0001876974],"category_scores_gemma":[0.001172312,0.00006731278,0.00003737621,0.00004251166,0.0002014379,0.0002024649,0.00002112111,0.0002227776,1.883972e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00008244983,"about_ca_system_score_gemma":0.0004165589,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001877711,"about_ca_topic_score_gemma":0.0001562217,"domain_scores_codex":[0.9988341,0.0001015854,0.000570188,0.0001180969,0.000275353,0.0001006265],"domain_scores_gemma":[0.9984674,0.0002505494,0.0005288491,0.00006747558,0.0004627226,0.0002229611],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0007892701,0.0005266199,0.995445,0.000105837,0.0001237599,4.29478e-7,0.00007768761,0.00006591361,0.00002382485,0.00000118322,0.00005227247,0.002788205],"study_design_scores_gemma":[0.004647728,0.004831709,0.9881006,0.0001391759,0.00003463745,0.00001552936,0.0001237021,0.002044531,0.000005306027,0.00001265051,4.605206e-7,0.00004394607],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9991531,0.00009854609,0.0002556515,0.00008935429,0.00006436458,0.0002943593,0.00003581758,0.000001754379,0.000007025691],"genre_scores_gemma":[0.9997733,0.0000929061,0.00005403571,0.00003436697,0.00002462829,0.000003752437,0.000007444795,0.000005946409,0.000003579846],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.007344372,"threshold_uncertainty_score":0.2838549,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2264465777","doi":"10.3111/13696998.2016.1151432","title":"Economic evaluation of nivolumab for the treatment of second-line advanced squamous NSCLC in Canada: a comparison of modeling approaches to estimate and extrapolate survival outcomes","year":2016,"lang":"en","type":"article","venue":"Journal of Medical Economics","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":79,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":true},"ca_institutions":"Bristol-Myers Squibb (Canada); McMaster University; McGill University; Golder Associates (Canada)","funders":"Bristol-Myers Squibb Canada","keywords":"Medicine; Erlotinib; Nivolumab; Docetaxel; Quality-adjusted life year; Oncology; Lung cancer; Quality of life (healthcare); Cost effectiveness; Survival analysis; Internal medicine; Cancer; Immunotherapy; Epidermal growth factor receptor; Risk analysis (engineering)","authors":[{"name":"Ron Goeree","is_ca":true},{"name":"Julie Villeneuve","is_ca":true},{"name":"Jeff Goeree","is_ca":true},{"name":"John R. Penrod","is_ca":false},{"name":"Lucinda Orsini","is_ca":false},{"name":"Amir Abbas Tahami Monfared","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1385477431919973,"gpt":0.3627472802013817,"spread":0.2241995370093845,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001337338,0.00009611607,0.000693582,0.0000850237,0.0000132888,0.000002303451,0.0000997529,0.00005514815,0.00005128989],"category_scores_gemma":[0.0001193586,0.00005413628,0.0001176771,0.00002307644,0.00005871821,0.00004889619,0.00000976942,0.0000508001,4.933685e-8],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000792122,"about_ca_system_score_gemma":0.001936575,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.01830122,"about_ca_topic_score_gemma":0.3750782,"domain_scores_codex":[0.9985247,0.00003584173,0.001034526,0.00009599634,0.0001953957,0.0001135494],"domain_scores_gemma":[0.9987001,0.0004787939,0.0005388386,0.0001210299,0.00006669628,0.00009457331],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","study_design_scores_codex":[0.008029884,0.0004004591,0.06129692,0.0001291508,0.0007106159,0.000001152422,0.001009759,0.05062151,0.0008603742,0.000111979,0.0000276606,0.8768005],"study_design_scores_gemma":[0.03040786,0.002468812,0.04774169,0.0003656011,0.000388476,0.00002455189,0.001427278,0.9121131,0.004387374,0.0002214359,0.0003201122,0.000133727],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9927999,0.001880127,0.001290823,0.003370334,0.0002472989,0.0003622411,0.00003543689,7.038232e-7,0.00001311041],"genre_scores_gemma":[0.9987219,0.0006617942,0.0005178958,0.00002931142,0.00004294231,0.000008869304,0.000001270042,0.000008961973,0.000007067466],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.8766668,"threshold_uncertainty_score":0.988236,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2911474691","doi":"10.1080/13696998.2019.1582059","title":"CAR T-cells: costs, comparisons, and commentary","year":2019,"lang":"en","type":"letter","venue":"Journal of Medical Economics","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":67,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre; Health Sciences Centre; Queen's University","funders":"","keywords":"Medicine; Intensive care medicine; Actuarial science; Economics","authors":[{"name":"Annette E. Hay","is_ca":true},{"name":"Matthew C. Cheung","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03332051064993916,"gpt":0.3124527859559872,"spread":0.279132275306048,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001688802,0.0002805501,0.001395748,0.0003049131,0.00003684516,0.00006112549,0.0005084986,0.001132624,0.004889747],"category_scores_gemma":[0.0001317802,0.0002335892,0.0003330384,0.00004593149,0.0002770686,0.00007235541,0.0001831533,0.006178195,0.00006579777],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007193105,"about_ca_system_score_gemma":0.0009042773,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00008878265,"about_ca_topic_score_gemma":0.00001268792,"domain_scores_codex":[0.9972464,0.0001580334,0.001041985,0.0002526475,0.0008959353,0.0004049492],"domain_scores_gemma":[0.9975965,0.0008404155,0.000584201,0.0003872246,0.0001173729,0.0004743043],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002260657,0.00007603866,0.0008460424,0.0002612492,0.0006127893,0.001194671,0.00004086013,0.000001291113,0.00007538485,0.000004460906,0.9849085,0.01175266],"study_design_scores_gemma":[0.00373439,0.0006033413,0.00005676069,0.0005286482,0.0002044612,0.002182466,0.0001030142,0.0005472615,0.000109925,0.00001671248,0.9917281,0.0001848697],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"commentary","genre_scores_codex":[0.03428308,0.002409668,0.00002647736,0.9598537,0.0018228,0.0003084807,0.00004029532,0.000007417092,0.001248093],"genre_scores_gemma":[0.000368138,0.02154642,0.0003615898,0.9628519,0.01217362,0.000002190502,0.00009464708,0.00008515977,0.00251629],"genre_candidate":"commentary","genre_consensus":"commentary","teacher_disagreement_score":0.03391494,"threshold_uncertainty_score":0.9961146,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2067254496","doi":"10.3111/13696998.2013.858634","title":"Cost-effectiveness of rivaroxaban compared with enoxaparin plus a vitamin K antagonist for the treatment of venous thromboembolism","year":2013,"lang":"en","type":"article","venue":"Journal of Medical Economics","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Medicine; Rivaroxaban; Vitamin K antagonist; Pulmonary embolism; Low molecular weight heparin; Enoxaparin sodium; Deep vein; Cost effectiveness; Venous thrombosis; Thrombosis; Cost-effectiveness analysis; Anticoagulant; Anesthesia; Internal medicine; Warfarin; Atrial fibrillation","authors":[{"name":"Patrick Lefèbvre","is_ca":true},{"name":"Craig I Coleman","is_ca":false},{"name":"Brahim Bookhart","is_ca":false},{"name":"Si-Tien Wang","is_ca":false},{"name":"Samir H. Mody","is_ca":false},{"name":"Kevin N. Tran","is_ca":false},{"name":"Daisy Y. Zhuo","is_ca":false},{"name":"Lynn Huynh","is_ca":false},{"name":"Edith A. Nutescu","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04347617111276509,"gpt":0.3114251669344934,"spread":0.2679489958217283,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008325042,0.0001853984,0.001566451,0.0001068693,0.00006315958,0.00002112652,0.0002825027,0.0001078009,0.0001533544],"category_scores_gemma":[0.00008652987,0.0001053857,0.000280692,0.00006912235,0.0002974933,0.00008318797,0.00003388415,0.0001406904,0.000003630112],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003170142,"about_ca_system_score_gemma":0.000513188,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004647588,"about_ca_topic_score_gemma":0.00006185732,"domain_scores_codex":[0.9984212,0.0000666694,0.00079148,0.0001523068,0.0003258135,0.0002425323],"domain_scores_gemma":[0.9976665,0.0008527899,0.000702711,0.0002945007,0.0002338716,0.0002495965],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.01895629,0.0825842,0.02539131,0.00763849,0.04028442,0.0003972158,0.02466074,0.01936103,0.004244524,0.04198223,0.02041719,0.7140824],"study_design_scores_gemma":[0.07958453,0.05067951,0.7165972,0.003527862,0.00575638,0.000999614,0.007657136,0.0269705,0.02421801,0.002240828,0.08091071,0.000857742],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9924916,0.0006541664,0.002100875,0.002187637,0.0003855075,0.001908237,0.00001929499,0.000005345055,0.0002473067],"genre_scores_gemma":[0.9938965,0.004709779,0.0007680418,0.000187023,0.0002700574,0.0001177582,0.000008640548,0.00002673412,0.00001540943],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7132246,"threshold_uncertainty_score":0.4297503,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1971766459","doi":"10.3111/13696998.2014.925462","title":"Satisfaction with botulinum toxin treatment in post-stroke spasticity: results from two cross-sectional surveys (patients and physicians)","year":2014,"lang":"en","type":"article","venue":"Journal of Medical Economics","topic":"Botulinum Toxin and Related Neurological Disorders","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Medicine; Spasticity; Botulinum toxin; Stroke (engine); Cross-sectional study; Patient satisfaction; Physical therapy; Surgery","authors":[{"name":"Djamel Bensmaïl","is_ca":false},{"name":"Angelika Hanschmann","is_ca":false},{"name":"Jörg Wissel","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01372402664093165,"gpt":0.2616882392279374,"spread":0.2479642125870057,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007719569,0.0001495375,0.0004243347,0.0001025033,0.00004150066,0.00003050304,0.00007154951,0.0002315298,0.0000778988],"category_scores_gemma":[0.0005646694,0.0001004811,0.00009652039,0.00004743095,0.0001598849,0.000110303,0.00002180577,0.0005385493,0.000008204325],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001272415,"about_ca_system_score_gemma":0.0001427597,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005328024,"about_ca_topic_score_gemma":0.001222183,"domain_scores_codex":[0.9984453,0.00016652,0.0006784938,0.0002298719,0.0002953212,0.0001844925],"domain_scores_gemma":[0.9986698,0.0005178999,0.0003514687,0.0000976389,0.00008803407,0.0002751841],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002318958,0.000375915,0.928837,0.000005093877,0.0001515136,0.00004109626,0.00009012566,0.000797829,0.00007657758,0.00002404961,0.0000224671,0.06725937],"study_design_scores_gemma":[0.01804439,0.002683692,0.9734557,0.0000486584,0.00004945449,0.00006126771,0.00002614192,0.004930165,0.00006893421,0.0001894262,0.000347971,0.00009419007],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9959384,0.0000430443,0.0003063522,0.002946528,0.000382301,0.0001179021,0.00006478783,0.000007851896,0.0001927875],"genre_scores_gemma":[0.9973863,0.0007100087,0.0002579913,0.001204733,0.0003476164,0.000001173672,0.00002832831,0.00001350013,0.00005028731],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.06716518,"threshold_uncertainty_score":0.4097499,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4311206227","doi":"10.1080/13696998.2022.2157596","title":"Socioeconomic burden of schizophrenia: a targeted literature review of types of costs and associated drivers across 10 countries","year":2022,"lang":"en","type":"review","venue":"Journal of Medical Economics","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Medicine; Socioeconomic status; Schizophrenia (object-oriented programming); Psychiatry; Demography; Environmental health; Gerontology; Population","authors":[{"name":"Anna Kotzeva","is_ca":false},{"name":"Deepali Mittal","is_ca":false},{"name":"Supriya Desai","is_ca":false},{"name":"Davneet Judge","is_ca":false},{"name":"Kunal Samanta","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02087375026887178,"gpt":0.3405422572108638,"spread":0.3196685069419921,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002024551,0.0003256549,0.004259382,0.0002721609,0.0000460952,0.00001697589,0.0004400809,0.0004852994,0.002490999],"category_scores_gemma":[0.001753681,0.0002408449,0.0009688463,0.0001748843,0.0004126637,0.00009832204,0.0002146092,0.001176127,0.000005903707],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006879891,"about_ca_system_score_gemma":0.004084155,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001899578,"about_ca_topic_score_gemma":0.00001579289,"domain_scores_codex":[0.9963884,0.0002608279,0.002219165,0.0002338975,0.0006210635,0.0002766699],"domain_scores_gemma":[0.9948269,0.0008921535,0.003221542,0.0002833756,0.0003390551,0.0004369815],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.002357559,0.0004040811,0.0001172585,0.1365251,0.007969136,0.0003828814,0.0003631673,0.000001678646,3.926091e-7,0.0003541161,0.00557393,0.8459507],"study_design_scores_gemma":[0.008543246,0.001914988,0.0001093328,0.2340888,0.003709261,0.001152621,0.0001741155,0.0000373329,0.000007802611,0.0001320084,0.7498251,0.0003054423],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.009437237,0.9879883,4.475414e-7,0.001066659,0.0002142684,0.0004793598,0.0007591423,0.000003821821,0.00005075052],"genre_scores_gemma":[0.0002570608,0.9989365,0.0001996253,0.00008061845,0.0002128839,0.00001009284,0.0001988404,0.00003652796,0.00006788255],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.8456453,"threshold_uncertainty_score":0.9984208,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4220928355","doi":"10.1080/13696998.2022.2053403","title":"Total cost of testing for genomic alterations associated with next-generation sequencing versus polymerase chain reaction testing strategies among patients with metastatic non-small cell lung cancer","year":2022,"lang":"en","type":"article","venue":"Journal of Medical Economics","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Group for Research in Decision Analysis","funders":"Janssen Scientific Affairs","keywords":"Medicine; KRAS; Internal medicine; Oncology; Personalized medicine; Polymerase chain reaction; Genetic testing; Cancer; Bioinformatics; Gene; Genetics; Colorectal cancer","authors":[{"name":"Julie Vanderpoel","is_ca":false},{"name":"Andrea L. Stevens","is_ca":false},{"name":"Bruno Émond","is_ca":true},{"name":"Marie‐Hélène Lafeuille","is_ca":true},{"name":"Annalise Hilts","is_ca":true},{"name":"Patrick Lefèbvre","is_ca":true},{"name":"Laura Morrison","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.05704098488559464,"gpt":0.2991262615221178,"spread":0.2420852766365232,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003988302,0.0001285467,0.0003255066,0.0001281737,0.0002310082,0.00004375108,0.0000675548,0.00003666041,0.00003496198],"category_scores_gemma":[0.0002597852,0.0001026941,0.00005628593,0.0001468179,0.00004426259,0.0002777303,0.00001803947,0.0002557563,7.687098e-8],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001354483,"about_ca_system_score_gemma":0.003048953,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005310583,"about_ca_topic_score_gemma":0.00049191,"domain_scores_codex":[0.9988257,0.0000429135,0.0005501324,0.0001435808,0.0002636249,0.0001740503],"domain_scores_gemma":[0.9980654,0.00040485,0.0009597606,0.00007822506,0.0003295506,0.0001622504],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","study_design_scores_codex":[0.002569474,0.001843499,0.2801888,0.0004279602,0.004137951,0.0001214083,0.005260507,0.6617211,0.01706425,0.000124317,0.0002879571,0.02625283],"study_design_scores_gemma":[0.03895307,0.009616062,0.08762837,0.0008567554,0.003822694,0.0001269581,0.007948472,0.8490065,0.001542113,0.00001940315,0.0000339012,0.0004457503],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9963695,0.0001226833,0.002164352,0.0002127762,0.0003163497,0.000597553,0.00009400896,0.000006869869,0.0001159153],"genre_scores_gemma":[0.9957918,0.00001255836,0.003640558,0.00007470683,0.0001944431,0.00009515857,0.0001365563,0.00002682623,0.00002742071],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1925604,"threshold_uncertainty_score":0.5408713,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3029092466","doi":"10.1080/13696998.2020.1776297","title":"Economic and humanistic burden associated with noncommunicable diseases among adults with depression and anxiety in the United States","year":2020,"lang":"en","type":"article","venue":"Journal of Medical Economics","topic":"Cardiac Health and Mental Health","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Medical Expenditure Panel Survey; Depression (economics); Anxiety; Quality of life (healthcare); Obesity; Diabetes mellitus; Cohort; Health care; Internal medicine; Psychiatry","authors":[{"name":"Eric S. Armbrecht","is_ca":false},{"name":"Anuj Shah","is_ca":false},{"name":"Patricia Schepman","is_ca":false},{"name":"Ruchit Shah","is_ca":false},{"name":"Elizabeth Pappadopulos","is_ca":false},{"name":"Richard Chambers","is_ca":false},{"name":"Jennifer Stephens","is_ca":false},{"name":"Seema Haider","is_ca":false},{"name":"Roger S. McIntyre","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01152816784599526,"gpt":0.2746695736899241,"spread":0.2631414058439288,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000612645,0.00009666224,0.0003796667,0.00005630323,0.00006940702,0.00002425996,0.000103028,0.00007493637,0.00002225475],"category_scores_gemma":[0.0001417019,0.00005515351,0.00002796464,0.00005355459,0.0001557482,0.00008410344,0.00004160323,0.0004754619,4.470669e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001322393,"about_ca_system_score_gemma":0.0004096191,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005585104,"about_ca_topic_score_gemma":0.000740692,"domain_scores_codex":[0.9990727,0.00009774879,0.0003858043,0.0001134076,0.0001562226,0.0001740983],"domain_scores_gemma":[0.9985909,0.0003298571,0.0002516591,0.00009437533,0.00002391281,0.0007092687],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.003564671,0.0001503436,0.9835832,0.0003616175,0.00009715874,0.0001481794,0.004793712,0.0005090238,5.519068e-7,0.00003380118,0.00119566,0.005562154],"study_design_scores_gemma":[0.01760573,0.003350457,0.9162042,0.002304291,0.000267898,0.00061882,0.01094025,0.04162019,0.000004759484,0.00005395442,0.006832779,0.000196713],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9858845,0.0004929193,0.000009357729,0.01326864,0.00002658213,0.0002065799,0.00001557369,0.000004712686,0.00009113616],"genre_scores_gemma":[0.9889314,0.007021701,0.00005189833,0.00378721,0.000155843,0.000003252081,0.00003480131,0.00001139478,0.000002454268],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.06737897,"threshold_uncertainty_score":0.2249095,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2160861863","doi":"10.3111/13696998.2011.571328","title":"Impact of upper and lower gastrointestinal blood loss on healthcare utilization and costs: a systematic review","year":2011,"lang":"en","type":"review","venue":"Journal of Medical Economics","topic":"Blood donation and transfusion practices","field":"Business, Management and Accounting","cited_by":46,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Medicine; Anemia; Health care; Upper gastrointestinal bleeding; Blood loss; Gastrointestinal bleeding; Retrospective cohort study; Emergency medicine; Intensive care medicine; Medical record; MEDLINE; Disease; Blood transfusion; Systematic review; Surgery; Internal medicine; Endoscopy","authors":[{"name":"Donna R. Parker","is_ca":false},{"name":"Xuemei Luo","is_ca":false},{"name":"Jessica J. Jalbert","is_ca":false},{"name":"Annlouise R. Assaf","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.06400063312899791,"gpt":0.3410981287151585,"spread":0.2770974955861606,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002020357,0.0002376315,0.001806824,0.0002959989,0.00003981461,0.00008494756,0.0002417187,0.0001434494,0.0003569854],"category_scores_gemma":[0.001364673,0.0001534234,0.0003448234,0.0001210613,0.00007110523,0.0004846875,0.00007730334,0.0004875601,0.00001070719],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004438669,"about_ca_system_score_gemma":0.0002811165,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0000479496,"about_ca_topic_score_gemma":0.00001205629,"domain_scores_codex":[0.9978485,0.00007967904,0.001529259,0.0001630034,0.0002509724,0.0001285509],"domain_scores_gemma":[0.9962797,0.0003070444,0.002955124,0.0001427351,0.0002303476,0.00008506141],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","study_design_scores_codex":[0.0000339626,0.0002642161,0.0002101631,0.7924091,0.0003824641,0.00005302019,0.000007277875,8.748883e-8,3.927572e-9,0.007058824,0.0002566069,0.1993243],"study_design_scores_gemma":[0.0008463527,0.0002622639,0.00005636824,0.9202918,0.004619705,0.003252932,0.00002399004,0.00005700748,1.240431e-8,0.000161827,0.07021522,0.0002124921],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0004210703,0.9977344,0.00001967057,0.000849847,0.000166928,0.0004565785,0.000007652165,0.000005223696,0.0003386733],"genre_scores_gemma":[0.0003595334,0.9983729,0.00005002629,0.0009143733,0.0002608518,0.000004959259,0.000008153409,0.00002302355,0.000006204855],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.1991118,"threshold_uncertainty_score":0.6256427,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2141205234","doi":"10.3111/13696998.2013.846262","title":"Flexible insulin dosing improves health-related quality-of-life (HRQoL): a time trade-off survey","year":2013,"lang":"en","type":"article","venue":"Journal of Medical Economics","topic":"Diabetes Management and Research","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Diabetes mellitus; Dosing; Basal (medicine); Population; Regimen; Type 2 diabetes; Basal insulin; Bolus (digestion); Quality of life (healthcare); Internal medicine; Endocrinology; Environmental health; Nursing","authors":[{"name":"Marc Evans","is_ca":false},{"name":"Henrik Holm Jensen","is_ca":false},{"name":"Mette Bøgelund","is_ca":false},{"name":"Jens Gundgaard","is_ca":false},{"name":"Barrie Chubb","is_ca":false},{"name":"Kamlesh Khunti","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.06106726985167935,"gpt":0.3454085567362911,"spread":0.2843412868846117,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.008465467,0.0001405481,0.0009968992,0.0002940684,0.00005242155,0.00004725532,0.0003532162,0.0002147395,0.001841596],"category_scores_gemma":[0.002339493,0.000106914,0.0002251403,0.0001850427,0.0002004793,0.0002261487,0.0001005229,0.0007651586,0.0001346825],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001365411,"about_ca_system_score_gemma":0.001144955,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002774155,"about_ca_topic_score_gemma":0.00001330493,"domain_scores_codex":[0.9965701,0.0003261477,0.001941467,0.0001588732,0.0006173385,0.0003861443],"domain_scores_gemma":[0.9972667,0.0006327339,0.0009667207,0.0002109086,0.0001279746,0.0007949487],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.001080522,0.001458991,0.02087992,0.0009736296,0.001474111,0.00002512114,0.0006182377,0.00007066011,0.0006407287,0.0007780726,0.05932503,0.912675],"study_design_scores_gemma":[0.0239324,0.004136581,0.8860258,0.001546224,0.000141061,0.0000766241,0.0007101009,0.04023835,0.0004135214,0.002872541,0.03926947,0.0006372672],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9583423,0.002648758,0.00006245657,0.03713169,0.0003791666,0.0002890035,0.000005249624,0.00001421025,0.001127123],"genre_scores_gemma":[0.9926553,0.002365848,0.0004771811,0.002699168,0.000348936,0.000003105964,0.00002425612,0.00003721894,0.001388985],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.9120377,"threshold_uncertainty_score":0.9990709,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2050417509","doi":"10.3111/13696998.2013.841705","title":"Patterns of relapse and associated cost burden in schizophrenia patients receiving atypical antipsychotics","year":2013,"lang":"en","type":"article","venue":"Journal of Medical Economics","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Medicine; Schizophrenia (object-oriented programming); Medicaid; Pediatrics; Internal medicine; Psychiatry; Health care","authors":[{"name":"Marie‐Hélène Lafeuille","is_ca":true},{"name":"Jonathan Gravel","is_ca":true},{"name":"Patrick Lefèbvre","is_ca":true},{"name":"John Fastenau","is_ca":false},{"name":"Erik Muser","is_ca":false},{"name":"Dilesh Doshi","is_ca":false},{"name":"Mei Sheng Duh","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01667223273340371,"gpt":0.2778757055518343,"spread":0.2612034728184305,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006868507,0.0001123597,0.000509312,0.00020105,0.00001959905,0.00002187141,0.0001444331,0.0001986489,0.0003290549],"category_scores_gemma":[0.001552754,0.00008616448,0.00009461772,0.00007441224,0.00006636712,0.0001290851,0.00006041943,0.0005877707,0.000009779585],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001792844,"about_ca_system_score_gemma":0.0003206262,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00005264708,"about_ca_topic_score_gemma":0.0001249525,"domain_scores_codex":[0.9983721,0.00007360186,0.00078744,0.0001267935,0.0004106906,0.000229394],"domain_scores_gemma":[0.998511,0.0002797662,0.0003455965,0.0001250118,0.0001714803,0.0005671598],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.006369109,0.0006888235,0.8950093,0.00004391167,0.0002200615,0.00008404906,0.000127729,0.000006572635,0.00001306144,0.0001277812,0.0005444377,0.09676512],"study_design_scores_gemma":[0.01633483,0.0006870349,0.9800559,0.0005441891,0.00003934163,0.00007073248,0.00008133392,0.00145432,0.00002742947,0.0005367352,0.0001009093,0.00006724254],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9949839,0.0001416391,0.00001844595,0.004384974,0.0001878454,0.0002371021,0.000007655055,0.000003264792,0.00003518255],"genre_scores_gemma":[0.9967227,0.002246055,0.0007085004,0.0001287302,0.0001508358,0.000003187151,0.000008387166,0.00001411926,0.00001751567],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.09669787,"threshold_uncertainty_score":0.360292,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2166937404","doi":"10.3111/13696998.2010.499749","title":"The cost effectiveness of palivizumab: a systematic review of the evidence","year":2010,"lang":"en","type":"review","venue":"Journal of Medical Economics","topic":"Respiratory viral infections research","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster Children's Hospital; Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Palivizumab; Medicine; Cost effectiveness; Population; Pediatrics; MEDLINE; Cost-effectiveness analysis; Cost–utility analysis; Intensive care medicine; Environmental health; Risk analysis (engineering); Internal medicine; Respiratory system","authors":[{"name":"Kelly Smart","is_ca":true},{"name":"Krista L. Lanctôt","is_ca":true},{"name":"Bosco Paes","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1409699726642448,"gpt":0.4714586418945917,"spread":0.3304886692303469,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.02378193,0.0002511005,0.004300967,0.0001633546,0.00007704846,0.00002459424,0.001447981,0.0004536463,0.00009863979],"category_scores_gemma":[0.04040024,0.0001036508,0.001628259,0.000346564,0.0006035321,0.0000887923,0.0002310592,0.002445377,0.00001523859],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003934766,"about_ca_system_score_gemma":0.00495973,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000007744312,"about_ca_topic_score_gemma":0.000007612888,"domain_scores_codex":[0.9927135,0.002494518,0.003346943,0.0001590243,0.001072464,0.0002135752],"domain_scores_gemma":[0.9846046,0.009405837,0.00401483,0.001023173,0.0006620672,0.0002895152],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","study_design_scores_codex":[0.00002515528,0.00005967353,0.00001183894,0.8898816,0.0004410283,0.00001082023,0.000003664468,2.403045e-7,7.338612e-7,0.0002312257,0.0002073311,0.1091267],"study_design_scores_gemma":[0.0002373529,0.0002245532,0.00001456856,0.8019828,0.002075977,0.001115505,0.000004902103,0.000007994197,0.000008956428,0.00002049999,0.1942438,0.00006313246],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001249664,0.9956689,0.00002508216,0.0004567509,0.0007714325,0.002821536,0.000007291988,0.000002152867,0.0001219239],"genre_scores_gemma":[0.00007275969,0.999371,0.00001051762,0.0001458102,0.0002475065,0.00008438435,6.387334e-7,0.00003073432,0.00003665014],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.1940365,"threshold_uncertainty_score":0.999856,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2035214881","doi":"10.3111/13696998.2014.979938","title":"Cost-effectiveness analysis of neoadjuvant pertuzumab and trastuzumab therapy for locally advanced, inflammatory, or early HER2-positive breast cancer in Canada","year":2014,"lang":"en","type":"article","venue":"Journal of Medical Economics","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"University of Ottawa; Ottawa Hospital; Roche (Canada)","funders":"","keywords":"Pertuzumab; Medicine; Trastuzumab; Oncology; Internal medicine; Breast cancer; Neoadjuvant therapy; Inflammatory breast cancer; Cancer","authors":[{"name":"C Attard","is_ca":false},{"name":"Amber N. Pepper","is_ca":false},{"name":"S. T. Brown","is_ca":false},{"name":"Melissa F Thompson","is_ca":false},{"name":"Per-Olof Thuresson","is_ca":false},{"name":"S. Yunger","is_ca":true},{"name":"Susan Dent","is_ca":true},{"name":"Alexander Paterson","is_ca":false},{"name":"George A. Wells","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02427292047140693,"gpt":0.3442561130701545,"spread":0.3199831925987475,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001883091,0.0001730587,0.001122948,0.0003259043,0.000032116,0.00001667007,0.0002433273,0.0001428619,0.0002742638],"category_scores_gemma":[0.0003864794,0.0001268817,0.0001690886,0.0002482292,0.0001604669,0.0001105683,0.0000364499,0.0004830119,2.346011e-7],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002189224,"about_ca_system_score_gemma":0.009132836,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.138711,"about_ca_topic_score_gemma":0.5153628,"domain_scores_codex":[0.9978677,0.0001671133,0.0008652643,0.0002286196,0.0005404524,0.0003308205],"domain_scores_gemma":[0.9973892,0.001150084,0.0003995968,0.000171605,0.000356778,0.0005327133],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.0108724,0.0001927276,0.1912447,0.0002386028,0.001746319,0.0001173548,0.0004528303,0.004465755,0.0001384397,0.00008002468,0.0001083007,0.7903426],"study_design_scores_gemma":[0.01409513,0.002182595,0.9236965,0.001240444,0.0003863018,0.0003141745,0.000598587,0.05315647,0.0007690275,0.00005262251,0.003274414,0.0002337756],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9938768,0.0006126849,0.001214225,0.003320165,0.0002118772,0.0005993465,0.0001330043,0.000002284946,0.00002959566],"genre_scores_gemma":[0.9947027,0.004402784,0.0001502049,0.0004505379,0.000199338,0.00005207184,0.000003757521,0.00002735978,0.00001125272],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7901088,"threshold_uncertainty_score":0.9964845,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2128124805","doi":"10.3111/13696998.2013.770747","title":"Cost effectiveness of transcatheter aortic valve replacement compared to medical management in inoperable patients with severe aortic stenosis: Canadian analysis based on the PARTNER Trial Cohort B findings","year":2013,"lang":"en","type":"article","venue":"Journal of Medical Economics","topic":"Cardiac Valve Diseases and Treatments","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"Vancouver General Hospital; University of British Columbia; Université Laval; Toronto General Hospital; University of Toronto","funders":"Edwards Lifesciences","keywords":"Medicine; Valve replacement; Stenosis; Emergency medicine; Cost effectiveness; Quality-adjusted life year; Cost-effectiveness analysis; Aortic valve replacement; Economic evaluation; Randomized controlled trial; Incremental cost-effectiveness ratio; Cohort; Cost–benefit analysis; Surgery; Internal medicine","authors":[{"name":"Rebecca Hancock","is_ca":false},{"name":"Christopher M. Feindel","is_ca":true},{"name":"Josep Rodés‐Cabau","is_ca":true},{"name":"John G. Webb","is_ca":true},{"name":"Ann Thompson","is_ca":false},{"name":"Kurt Banz","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01543467519830726,"gpt":0.295500422946994,"spread":0.2800657477486867,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001569275,0.0001830225,0.0008344441,0.0004212446,0.00004441035,0.00002857888,0.0002152944,0.0001066593,0.001567468],"category_scores_gemma":[0.000222217,0.0001089923,0.0009257902,0.000291918,0.00006393361,0.00006045765,0.00002195288,0.0002638476,0.0000128226],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006778995,"about_ca_system_score_gemma":0.0006973228,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003519712,"about_ca_topic_score_gemma":0.0008268078,"domain_scores_codex":[0.9975414,0.0002009509,0.0008009804,0.0002306875,0.0009197935,0.0003062435],"domain_scores_gemma":[0.9978344,0.0003392221,0.0001921182,0.0002997227,0.0001419895,0.001192493],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.009888724,0.001215706,0.9766607,0.000064985,0.008009934,0.00001262608,0.00008609215,0.001929373,9.955338e-8,0.00002053437,0.0002349333,0.001876349],"study_design_scores_gemma":[0.03592385,0.001187616,0.9542501,0.00050652,0.003507697,0.000001784069,0.0001208389,0.004296332,0.000006118264,0.00001037912,0.00007454654,0.00011421],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9954147,0.00001349956,0.00005899087,0.002028837,0.0001513752,0.002004619,0.00002182515,0.000002526243,0.0003036458],"genre_scores_gemma":[0.9978592,0.00004046422,0.00003384485,0.001791543,0.00003877056,0.0001739162,0.00003502257,0.00001651963,0.00001065549],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02603513,"threshold_uncertainty_score":0.9993452,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1997932743","doi":"10.3111/13696998.2011.622323","title":"Health and economic impact of PHiD-CV in Canada and the UK: a Markov modelling exercise","year":2011,"lang":"en","type":"article","venue":"Journal of Medical Economics","topic":"Pneumonia and Respiratory Infections","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"GlaxoSmithKline (Canada); McMaster University","funders":"","keywords":"Medicine; Haemophilus influenzae; Conjugate vaccine; Cohort; Pneumococcal conjugate vaccine; Epidemiology; Disease burden; Pandemic; Pneumonia; Herd immunity; Streptococcus pneumoniae; Intensive care medicine; Disease; Environmental health; Vaccination; Infectious disease (medical specialty); Immunology; Population; Coronavirus disease 2019 (COVID-19); Immunization; Internal medicine; Antibiotics","authors":[{"name":"Gerhart Knerer","is_ca":false},{"name":"Afisi Ismaila","is_ca":true},{"name":"David Pearce","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02227451260633569,"gpt":0.2648541504847154,"spread":0.2425796378783797,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008512744,0.00007252466,0.0004862628,0.00008782707,0.00002689564,0.000004672995,0.00007112206,0.00005469632,0.00009161826],"category_scores_gemma":[0.00004917166,0.00004347714,0.00007602953,0.00002142448,0.0001254304,0.00004696976,0.00002396791,0.0002967095,2.567153e-7],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004756277,"about_ca_system_score_gemma":0.00592742,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.4436914,"about_ca_topic_score_gemma":0.2837954,"domain_scores_codex":[0.9991117,0.00003463267,0.0005842064,0.00006706836,0.00007507302,0.0001273673],"domain_scores_gemma":[0.9990639,0.0001061717,0.0003181752,0.00008237684,0.00001735625,0.0004120188],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00260809,0.0001729735,0.926201,0.0002600038,0.0005553382,0.0001436283,0.004105356,0.005913042,0.00001387136,0.0008370125,0.001740911,0.05744881],"study_design_scores_gemma":[0.03860315,0.002626968,0.4987152,0.002369493,0.0003706504,0.007739516,0.003505219,0.4394085,0.00006331593,0.004007307,0.002055221,0.0005354746],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9961657,0.0008582631,0.00005171115,0.002540914,0.0001435592,0.00008546707,0.000004369529,7.798675e-7,0.000149226],"genre_scores_gemma":[0.9888813,0.01037942,0.00006412376,0.0005873174,0.00007597038,9.115204e-7,2.359481e-7,0.0000059807,0.000004661744],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4334954,"threshold_uncertainty_score":0.9997081,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2141479869","doi":"10.3111/13696998.2013.852097","title":"Economic analysis of bevacizumab, cetuximab, and panitumumab with fluoropyrimidine-based chemotherapy in the first-line treatment of KRAS wild-type metastatic colorectal cancer (mCRC)","year":2013,"lang":"en","type":"article","venue":"Journal of Medical Economics","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"Roche (Canada)","funders":"","keywords":"Cetuximab; Medicine; Panitumumab; Bevacizumab; KRAS; Colorectal cancer; Internal medicine; Oncology; Chemotherapy; Cancer","authors":[{"name":"Donna Lawrence","is_ca":false},{"name":"Michael Maschio","is_ca":false},{"name":"Kevin J. Leahy","is_ca":false},{"name":"S. Yunger","is_ca":true},{"name":"Jacob C. Easaw","is_ca":false},{"name":"Milton C. Weinstein","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02097388101552049,"gpt":0.2953600767874404,"spread":0.2743861957719199,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003082944,0.0001908276,0.001202606,0.0002781005,0.00003411108,0.00001379706,0.0001293086,0.00006427021,0.0005447704],"category_scores_gemma":[0.00003669216,0.0001026274,0.0002163063,0.0002047936,0.0002259768,0.0000737831,0.00001338007,0.0001216221,8.38557e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004498819,"about_ca_system_score_gemma":0.0005858063,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002020179,"about_ca_topic_score_gemma":0.006602013,"domain_scores_codex":[0.9986379,0.0000395392,0.0007742327,0.0001578689,0.0002214089,0.0001690617],"domain_scores_gemma":[0.9987316,0.0003082488,0.0005701199,0.0001428507,0.0001155954,0.0001315953],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0164779,0.006072223,0.7049829,0.0003899698,0.03084568,0.0002081027,0.007882775,0.01131912,0.0002025378,0.0001935896,0.0005440841,0.2208811],"study_design_scores_gemma":[0.05597882,0.03167912,0.8100026,0.0004245273,0.0133704,0.0002672481,0.00287642,0.07680028,0.004154343,0.000223221,0.003735891,0.0004871433],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9890127,0.002148297,0.00001366269,0.008310235,0.00007567208,0.0003366674,0.00002306524,0.000002293561,0.0000773892],"genre_scores_gemma":[0.9916903,0.007544415,0.0002600084,0.0003725082,0.0000760896,0.00002810651,0.000006517772,0.00001352974,0.000008566343],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.220394,"threshold_uncertainty_score":0.5964854,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1981297777","doi":"10.3111/13696990903442155","title":"The cost effectiveness of palivizumab in term Inuit infants in the Eastern Canadian Arctic","year":2009,"lang":"en","type":"article","venue":"Journal of Medical Economics","topic":"Respiratory viral infections research","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"Children's Hospital of Eastern Ontario; St. Joseph’s Healthcare Hamilton; McMaster Children's Hospital; St. Michael's Hospital; Sunnybrook Health Science Centre","funders":"Abbott Laboratories","keywords":"Palivizumab; Medicine; Pediatrics; Gestational age; Cost effectiveness; Cost-effectiveness analysis; Emergency medicine; Respiratory system; Pregnancy; Internal medicine","authors":[{"name":"Derrick Y. Tam","is_ca":true},{"name":"Anna Banerji","is_ca":true},{"name":"Bosco Paes","is_ca":true},{"name":"Charles Hui","is_ca":true},{"name":"Jean‐Éric Tarride","is_ca":true},{"name":"Krista L. Lanctôt","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03774025749135262,"gpt":0.3618556405404861,"spread":0.3241153830491335,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006173746,0.00008307456,0.0003257114,0.0003488921,0.00004303226,0.00004274123,0.0004143457,0.000132968,0.00004983666],"category_scores_gemma":[0.002154091,0.00004708173,0.00008411907,0.0002195091,0.0001539419,0.0001230884,0.00002102665,0.0009411301,0.000007548711],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008267155,"about_ca_system_score_gemma":0.002120369,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.008267484,"about_ca_topic_score_gemma":0.1416891,"domain_scores_codex":[0.9982098,0.0004211267,0.000660071,0.00008506245,0.0003626021,0.0002612985],"domain_scores_gemma":[0.9983681,0.0008449503,0.0001743806,0.0002150021,0.0001107902,0.0002867408],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0007914634,0.0002997332,0.7789691,0.00009239192,0.00007053899,0.0005506363,0.0008899739,0.0001824481,0.00006330403,0.001114558,0.0001163024,0.2168596],"study_design_scores_gemma":[0.002586133,0.0006957581,0.9914923,0.0005776462,0.00001258077,0.0004268466,0.0002429856,0.0008991645,0.00006765786,0.0007695729,0.002175178,0.00005415842],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9934427,0.0002271303,0.000006536627,0.0052089,0.0001420206,0.000306215,0.000001916525,9.401541e-7,0.0006636156],"genre_scores_gemma":[0.9985489,0.0004149976,0.000005011836,0.000874723,0.0001353634,0.000005169748,4.528303e-7,0.000006162729,0.000009231151],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2168054,"threshold_uncertainty_score":0.9983366,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2025655213","doi":"10.3111/13696998.2014.897628","title":"Medical cost savings associated with an extended-release opioid with abuse-deterrent technology in the US","year":2014,"lang":"en","type":"article","venue":"Journal of Medical Economics","topic":"Opioid Use Disorder Treatment","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Purdue Pharma (Canada)","funders":"","keywords":"Medicine; Oxycodone; Medicaid; Medical prescription; Pharmacy; Opioid; Propensity score matching; Substance abuse; Medicare Part D; Opioid abuse; Emergency medicine; Observational study; Prescription drug; Psychiatry; Family medicine; Internal medicine; Health care; Pharmacology","authors":[{"name":"Louis F. Rossiter","is_ca":false},{"name":"Noam Y. Kirson","is_ca":false},{"name":"Amie Shei","is_ca":false},{"name":"Alan G. White","is_ca":false},{"name":"Howard G. Birnbaum","is_ca":false},{"name":"Rami Ben‐Joseph","is_ca":true},{"name":"Edward Michna","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.00829051050439042,"gpt":0.258836376412609,"spread":0.2505458659082186,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001910237,0.0002283417,0.0006801559,0.000280043,0.00005430713,0.00003195995,0.0005970981,0.0003800337,0.0002248764],"category_scores_gemma":[0.00104473,0.0001223056,0.00008736915,0.0002094887,0.0003560976,0.0001229966,0.00003676813,0.001223083,0.00001047622],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003241349,"about_ca_system_score_gemma":0.001120992,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004616647,"about_ca_topic_score_gemma":0.0007884505,"domain_scores_codex":[0.9975266,0.0001437538,0.0007516055,0.000241172,0.0009572136,0.0003796591],"domain_scores_gemma":[0.9981074,0.0002968261,0.0004821926,0.0003698565,0.0001190808,0.0006246152],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.005417106,0.01727638,0.5761692,0.000215277,0.002089272,0.007341451,0.008558596,0.0004076213,0.00002099173,0.005524707,0.002642431,0.374337],"study_design_scores_gemma":[0.09864658,0.04509941,0.7023571,0.007700933,0.001942597,0.02175544,0.01112107,0.05367238,0.0002831452,0.004545003,0.05132973,0.001546617],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9740463,0.0001976478,0.0003131891,0.02479262,0.0001522764,0.0002914784,0.000002621026,0.00002425263,0.0001796234],"genre_scores_gemma":[0.9947066,0.0008143304,0.0004412639,0.003709912,0.0002466796,0.00002033683,0.00001262379,0.000037145,0.00001112257],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3727903,"threshold_uncertainty_score":0.5313757,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3130545975","doi":"10.3111/13696998.2013.784591","title":"Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement","year":2013,"lang":"en","type":"editorial","venue":"Journal of Medical Economics","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":37,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Ottawa Hospital; Institute of Health Economics; University of Ottawa","funders":"","keywords":"Checklist; Government (linguistics); Medicine; Statement (logic); Delphi method; Psychological intervention; Consolidated Standards of Reporting Trials; Systematic review; Economic evaluation; Delphi; MEDLINE; Public relations; Medical education; Political science; Psychology; Nursing; Law; Computer science","authors":[{"name":"Don Husereau","is_ca":true},{"name":"Michael Drummond","is_ca":false},{"name":"Stavros Petrou","is_ca":false},{"name":"Chris Carswell","is_ca":false},{"name":"David Moher","is_ca":true},{"name":"Dan Greenberg","is_ca":false},{"name":"Federico Augustovski","is_ca":false},{"name":"Andrew Briggs","is_ca":false},{"name":"Josephine Mauskopf","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.3160740589379751,"gpt":0.5300803307364624,"spread":0.2140062717984873,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaresearch","research_integrity","insufficient_payload"],"category_scores_codex":[0.2638452,0.000735586,0.005696684,0.001102256,0.0002906886,0.0005094449,0.001556656,0.001843426,0.009154288],"category_scores_gemma":[0.09262637,0.0008725236,0.0007800011,0.0001260328,0.0002438528,0.001204874,0.0002523095,0.002528795,0.001297923],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.01878749,"about_ca_system_score_gemma":0.03166425,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002113843,"about_ca_topic_score_gemma":0.0005935592,"domain_scores_codex":[0.952037,0.001428013,0.04240819,0.001193186,0.001775186,0.001158388],"domain_scores_gemma":[0.893629,0.003913715,0.09816726,0.001149965,0.001423745,0.001716358],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00004496143,0.0001101627,0.0001693106,0.0005729935,0.0006529965,0.000008096772,0.0006608972,0.0008087307,5.301038e-8,0.002653756,0.9921255,0.002192563],"study_design_scores_gemma":[0.003242908,0.0004055363,0.00007077106,0.0008434168,0.00006716827,0.00004920465,0.0008604433,0.01510785,0.000001209619,0.006534748,0.9721338,0.000682897],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"editorial","genre_gemma":"editorial","genre_scores_codex":[0.01274167,0.01123511,0.001921875,0.08751632,0.8784982,0.001960926,0.00370278,0.00005877311,0.002364331],"genre_scores_gemma":[0.003782509,0.02770222,0.003587735,0.01135348,0.9505395,0.0002140441,0.001422417,0.0004101815,0.0009878649],"genre_candidate":"editorial","genre_consensus":"editorial","teacher_disagreement_score":0.1712188,"threshold_uncertainty_score":0.9997724,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3155883542","doi":"10.1080/13696998.2021.1917140","title":"Cost-effectiveness of pembrolizumab compared with chemotherapy in the US for women with previously treated deficient mismatch repair or high microsatellite instability unresectable or metastatic endometrial cancer","year":2021,"lang":"en","type":"article","venue":"Journal of Medical Economics","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Merck Canada Inc. (Canada)","funders":"","keywords":"Medicine; Pembrolizumab; Endometrial cancer; Microsatellite instability; Oncology; Internal medicine; Chemotherapy; Cost effectiveness; Cancer; Quality of life (healthcare); Clinical trial; Immunotherapy","authors":[{"name":"Elizabeth Thurgar","is_ca":false},{"name":"Mark Gouldson","is_ca":false},{"name":"Suzette M. Matthijsse","is_ca":false},{"name":"Mayur M. Amonkar","is_ca":false},{"name":"Patricia Marinello","is_ca":false},{"name":"Navneet Upadhyay","is_ca":false},{"name":"Chizoba Nwankwo","is_ca":false},{"name":"Raquel Aguiar‐Ibáñez","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0601413884066394,"gpt":0.3432891180794398,"spread":0.2831477296728004,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002510124,0.000225898,0.001401184,0.0001823159,0.00004462119,0.00002892224,0.0002299622,0.00009866251,0.0005672573],"category_scores_gemma":[0.0008413544,0.0001024908,0.0001761411,0.0008234294,0.0001716532,0.00009048696,0.00002393042,0.00031013,4.108592e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001019944,"about_ca_system_score_gemma":0.002697926,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000451868,"about_ca_topic_score_gemma":0.001165476,"domain_scores_codex":[0.9975086,0.0003696568,0.0009387789,0.0002804088,0.0005186324,0.0003838616],"domain_scores_gemma":[0.9959385,0.002587283,0.0005285846,0.000275144,0.0003731614,0.0002973599],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8543931,0.008292967,0.08785012,0.003910207,0.005105469,0.001268858,0.002715032,0.002097207,0.0003846169,0.0001013985,0.0001064969,0.03377455],"study_design_scores_gemma":[0.6481549,0.05335576,0.2106081,0.005388281,0.00292527,0.004025268,0.005776983,0.001822879,0.04099234,0.0005300992,0.02544767,0.0009724837],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9959916,0.00100797,0.0001843119,0.0009307641,0.0001448921,0.001612495,0.00007842524,0.000007753631,0.00004180741],"genre_scores_gemma":[0.9955874,0.002281731,0.001135786,0.0004944733,0.0001308504,0.0002696639,0.00001816511,0.00002797358,0.00005397817],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2062382,"threshold_uncertainty_score":0.621107,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4223492032","doi":"10.1080/13696998.2022.2063603","title":"Carbon footprint and associated costs of asthma exacerbation care among UK adults","year":2022,"lang":"en","type":"article","venue":"Journal of Medical Economics","topic":"Climate Change and Health Impacts","field":"Environmental Science","cited_by":36,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Institute of Health Economics","funders":"","keywords":"Carbon footprint; Exacerbation; Greenhouse gas; Asthma; Medicine; Asthma exacerbations; Environmental health; Population; Internal medicine","authors":[{"name":"Kalé Kponee-Shovein","is_ca":false},{"name":"Jessica Marvel","is_ca":false},{"name":"Ryotaro Ishikawa","is_ca":false},{"name":"Abhay Choubey","is_ca":false},{"name":"Harneet Kaur","is_ca":false},{"name":"Praveen Thokala","is_ca":true},{"name":"Khadidja Ngom","is_ca":false},{"name":"Iman Fakih","is_ca":false},{"name":"Todd Schatzki","is_ca":false},{"name":"James Signorovitch","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01600650891459382,"gpt":0.2557213518250877,"spread":0.2397148429104939,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008764224,0.00005677279,0.0001897245,0.00003790327,0.00005877221,0.000007081574,0.0001437408,0.00006419666,0.0008205861],"category_scores_gemma":[0.0001963877,0.00005408615,0.00003739799,0.00004466422,0.00006941192,0.00003343939,0.0001840587,0.0002667571,7.839631e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007476121,"about_ca_system_score_gemma":0.00005261633,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007091348,"about_ca_topic_score_gemma":0.001461205,"domain_scores_codex":[0.9990077,0.00005538928,0.0004028483,0.00008183009,0.00031275,0.0001394925],"domain_scores_gemma":[0.999105,0.00007733099,0.0004795333,0.00006063388,0.00001234255,0.0002651947],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0002517591,0.0001825449,0.8327124,0.00005758817,0.00003502343,0.00004476931,0.008854291,0.001984137,0.00009777873,0.00006697012,0.0008174757,0.1548953],"study_design_scores_gemma":[0.002970882,0.001269811,0.9756331,0.0001942236,0.00002415432,0.00008820469,0.008338166,0.009131135,0.0001861851,0.0002453437,0.001749024,0.0001697627],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9975211,0.0001710176,0.000001879126,0.001219428,0.0002327366,0.00006920887,0.000009466431,0.000002113584,0.0007730365],"genre_scores_gemma":[0.9989821,0.0007112311,0.00002292338,0.0002043706,0.00006074238,0.000001742856,0.00000376708,0.000006113298,0.000007004206],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1547255,"threshold_uncertainty_score":0.8984842,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2090977676","doi":"10.3111/13696998.2015.1025793","title":"Utilities for asthma and COPD according to category of severity: a comprehensive literature review","year":2015,"lang":"en","type":"review","venue":"Journal of Medical Economics","topic":"Chronic Obstructive Pulmonary Disease (COPD) Research","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; COPD; Asthma; Pulmonary disease; Quality of life (healthcare); MEDLINE; Internal medicine; Severity of illness; Physical therapy; Disease; Intensive care medicine","authors":[{"name":"Thomas R. Einarson","is_ca":true},{"name":"Basil G. Bereza","is_ca":true},{"name":"T. Anders Nielsen","is_ca":false},{"name":"M. Hemels","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.07019135828087612,"gpt":0.3909560922612119,"spread":0.3207647339803357,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001912724,0.0003893901,0.00425284,0.0003885433,0.00003682858,0.00003760848,0.0004571151,0.0004670306,0.0001384042],"category_scores_gemma":[0.001607332,0.0002941532,0.0008331254,0.0002075176,0.0002509795,0.00014783,0.000295894,0.001199353,0.000006077923],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006705873,"about_ca_system_score_gemma":0.005015791,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000005706452,"about_ca_topic_score_gemma":0.000002214626,"domain_scores_codex":[0.9967363,0.0001912716,0.00173937,0.0003366103,0.000642307,0.0003541715],"domain_scores_gemma":[0.9956174,0.0006675276,0.001036035,0.0003563522,0.0009819904,0.001340679],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000140261,0.00006817696,0.000009545101,0.2094837,0.0004579292,0.0001729393,0.000065564,1.567001e-7,5.449879e-8,0.0001579262,0.01285507,0.7765887],"study_design_scores_gemma":[0.000976673,0.0002843433,0.00002626397,0.1474525,0.0008098457,0.00342783,0.0002496685,0.00004859421,1.602913e-7,0.0001813562,0.8463684,0.000174366],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0003882707,0.9951153,0.00002895409,0.002067823,0.0004503849,0.001456464,0.0003132539,0.000005295001,0.0001742135],"genre_scores_gemma":[0.0000149042,0.9971882,0.0005620794,0.0009352582,0.0009749836,0.00003530956,0.00007929772,0.00005834993,0.0001516775],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.8335134,"threshold_uncertainty_score":0.9999511,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2290821530","doi":"10.3111/13696998.2016.1151431","title":"A global economic model to assess the cost-effectiveness of new treatments for advanced breast cancer in Canada","year":2016,"lang":"en","type":"article","venue":"Journal of Medical Economics","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":34,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"Hôpital Notre-Dame; Université de Montréal","funders":"","keywords":"Medicine; Lapatinib; Letrozole; Anastrozole; Breast cancer; Quality-adjusted life year; Context (archaeology); Cost effectiveness; Metastatic breast cancer; Oncology; Internal medicine; Pharmacoeconomics; Economic evaluation; Quality of life (healthcare); Tamoxifen; Cancer; Trastuzumab; Intensive care medicine","authors":[{"name":"C. Beauchemin","is_ca":true},{"name":"Nathalie Letarte","is_ca":true},{"name":"K. Mathurin","is_ca":true},{"name":"Louise Yelle","is_ca":true},{"name":"Jean Lachaîne","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.05054085207464628,"gpt":0.3117716208106228,"spread":0.2612307687359765,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00131056,0.0001947233,0.0009106839,0.0001090259,0.00003308463,0.00002309942,0.000682001,0.0001267777,0.0002261877],"category_scores_gemma":[0.0002360212,0.0001433769,0.000199073,0.00007216427,0.0000575015,0.0003750114,0.00006731253,0.0001104886,0.000008654775],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.005490661,"about_ca_system_score_gemma":0.005611456,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.158168,"about_ca_topic_score_gemma":0.4462944,"domain_scores_codex":[0.9979306,0.00002071202,0.001339973,0.0002686864,0.00005796819,0.000382018],"domain_scores_gemma":[0.9979212,0.0003581321,0.0009979692,0.0002355415,0.00005609185,0.0004310324],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002915122,0.0001854617,0.4009845,0.00008304968,0.0007187783,0.000009592787,0.0001549238,0.1654723,0.00001806515,0.1214183,0.006596254,0.3014437],"study_design_scores_gemma":[0.02592952,0.0005876102,0.7744437,0.001115573,0.0001097056,0.0001312003,0.0002028998,0.03988627,0.0003409133,0.1234016,0.0327298,0.001121188],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9692291,0.0007064055,0.01508704,0.01008515,0.001469764,0.0005665376,0.002329487,0.000002569601,0.0005239639],"genre_scores_gemma":[0.996538,0.00209191,0.0003029207,0.0006173555,0.0002865984,0.00005122728,0.000001161149,0.00002337076,0.00008742078],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3734592,"threshold_uncertainty_score":0.9983271,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2072574820","doi":"10.3111/13696998.2013.772058","title":"Medical costs and healthcare resource use in patients with lupus nephritis and neuropsychiatric lupus in an insured population","year":2013,"lang":"en","type":"article","venue":"Journal of Medical Economics","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University","funders":"GlaxoSmithKline","keywords":"Medicine; Lupus nephritis; Systemic lupus erythematosus; Population; Internal medicine; Health care; Lupus erythematosus; Disease; Immunology","authors":[{"name":"Daniel E. Furst","is_ca":false},{"name":"Ann E. Clarke","is_ca":true},{"name":"Ancilla W. Fernandes","is_ca":false},{"name":"Tim Bancroft","is_ca":false},{"name":"Kavita Gajria","is_ca":false},{"name":"Warren Greth","is_ca":false},{"name":"Şerban R. Iorga","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01406123559023009,"gpt":0.2704657022021613,"spread":0.2564044666119312,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001345181,0.0001475407,0.0005974906,0.0005114962,0.00003097166,0.00006543445,0.0001628204,0.0003105987,0.00006702171],"category_scores_gemma":[0.001120328,0.0001118394,0.00003052328,0.0001919166,0.0001134937,0.0004284482,0.00007480247,0.0009029962,0.000002066042],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002961393,"about_ca_system_score_gemma":0.0003646331,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001007786,"about_ca_topic_score_gemma":0.002673027,"domain_scores_codex":[0.9972939,0.0002852408,0.0009949746,0.0002422496,0.0008779514,0.0003057013],"domain_scores_gemma":[0.9979733,0.0002886324,0.0002961123,0.0001835064,0.000138377,0.001120022],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0004787222,0.0001804554,0.967855,0.0001425617,0.0000143589,0.0001232268,0.000299325,0.000002198606,3.933854e-7,0.00003849236,0.0003298673,0.03053543],"study_design_scores_gemma":[0.01111258,0.001009546,0.9754395,0.001029005,0.00001027013,0.008549682,0.000350959,0.002052026,1.793322e-7,0.00005947594,0.0002860815,0.0001007225],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.991041,0.000584794,0.00000389694,0.007570885,0.0003152479,0.0004573989,0.000002977011,0.000005899412,0.00001790419],"genre_scores_gemma":[0.9974052,0.001102227,0.0002224771,0.001014101,0.0001939134,0.000005789626,0.00001172059,0.00002870123,0.00001592524],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0304347,"threshold_uncertainty_score":0.4560679,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2107285363","doi":"10.3111/13696998.2014.923892","title":"A Canadian cost-effectiveness analysis of transcatheter mitral valve repair with the MitraClip system in high surgical risk patients with significant mitral regurgitation","year":2014,"lang":"en","type":"article","venue":"Journal of Medical Economics","topic":"Cardiac Valve Diseases and Treatments","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"Montreal Heart Institute","funders":"","keywords":"MitraClip; Medicine; Mitral regurgitation; Quality-adjusted life year; Mitral valve; Mitral valve repair; Quality of life (healthcare); Heart failure; Cost–utility analysis; Cardiology; Surgery; Cost effectiveness; Intensive care medicine; Internal medicine; Risk analysis (engineering)","authors":[{"name":"Heather Cameron","is_ca":false},{"name":"Lisa Bernard","is_ca":false},{"name":"Vincent Garmo","is_ca":false},{"name":"John Hernandez","is_ca":false},{"name":"Anita Asgar","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.005844515260005902,"gpt":0.253686271921591,"spread":0.2478417566615851,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001313758,0.0001679101,0.0008593441,0.000361566,0.00004439273,0.00001632452,0.000122107,0.0001270141,0.00003005442],"category_scores_gemma":[0.00008160603,0.00009236662,0.003898649,0.0002848082,0.0001176681,0.00008014123,0.000005870239,0.0003105034,0.000001060036],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005610962,"about_ca_system_score_gemma":0.0005910546,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0108018,"about_ca_topic_score_gemma":0.008831537,"domain_scores_codex":[0.9982063,0.0003085836,0.0005855942,0.0001962654,0.0004519449,0.0002513564],"domain_scores_gemma":[0.9980149,0.0005055488,0.0004555898,0.0002227042,0.0002045275,0.0005967139],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002264983,0.0003483344,0.9737966,0.00006827623,0.01826547,0.00005773771,0.0001596392,0.002047576,1.037023e-7,0.0001686491,0.00001331497,0.002809279],"study_design_scores_gemma":[0.008761932,0.0009820171,0.9730505,0.000269194,0.01468556,0.00003122611,0.0002466019,0.001686552,0.000003079143,0.000008638878,0.0001740255,0.0001006094],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9986312,0.0001294083,0.0001230139,0.0003808503,0.00009462373,0.0004430428,0.0001037323,0.000005521752,0.00008855963],"genre_scores_gemma":[0.9996323,0.00004940722,0.00007746079,0.00006932644,0.00008573281,0.00001729774,0.00004695885,0.0000180744,0.000003449464],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006496949,"threshold_uncertainty_score":0.9957854,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1968579243","doi":"10.3111/13696998.2014.909436","title":"Inflammatory bowel disease: healthcare costs for patients who are adherent or non-adherent with infliximab therapy","year":2014,"lang":"en","type":"article","venue":"Journal of Medical Economics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":32,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Western University; Robarts Clinical Trials","funders":"Janssen Scientific Affairs","keywords":"Medicine; Infliximab; Inflammatory bowel disease; Disease; Health care; Internal medicine; Intensive care medicine","authors":[{"name":"George J. Wan","is_ca":false},{"name":"Chris M Kozma","is_ca":false},{"name":"Terra Slaton","is_ca":false},{"name":"William H. Olson","is_ca":false},{"name":"Brian G. Feagan","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.008427640331969043,"gpt":0.251802811231127,"spread":0.243375170899158,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005751189,0.0002328054,0.0003327696,0.00005875013,0.00008043431,0.00004150457,0.0004376158,0.0002172333,0.00006254315],"category_scores_gemma":[0.0003542772,0.0001658366,0.0001984386,0.00002040006,0.0001108108,0.00001878295,0.00007428289,0.0002144905,0.000005430697],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001170356,"about_ca_system_score_gemma":0.0009653596,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000002222594,"about_ca_topic_score_gemma":0.00009131864,"domain_scores_codex":[0.9983382,0.00009258916,0.0006768442,0.0002531108,0.0003287214,0.0003105094],"domain_scores_gemma":[0.9976568,0.00004578562,0.0007353429,0.0003163888,0.0003405633,0.000905127],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.03324979,0.001481921,0.8453472,0.0008461255,0.0008104964,0.000177636,0.0001895212,0.0006663598,0.00007330149,0.0004582437,0.03197467,0.08472479],"study_design_scores_gemma":[0.02452877,0.004165588,0.7887627,0.0008903631,0.00008962618,0.00003083167,0.0001858797,0.002291731,0.0004600543,0.0001487131,0.1776992,0.0007465217],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9969968,0.000304511,0.0004337349,0.001343906,0.0004389777,0.0003748978,0.00005549168,0.000004949673,0.00004676811],"genre_scores_gemma":[0.9939873,0.001616931,0.0002081097,0.002621446,0.001267858,0.00006055943,0.00006036453,0.00005976876,0.0001176207],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1457245,"threshold_uncertainty_score":0.676262,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2130922075","doi":"10.3111/13696998.2012.737393","title":"Cost-effectiveness of denosumab in the treatment of postmenopausal osteoporosis in Canada","year":2012,"lang":"en","type":"article","venue":"Journal of Medical Economics","topic":"Bone health and osteoporosis research","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"Programs for Assessment of Technology in Health Research Institute; McMaster University; St. Joseph’s Healthcare Hamilton; Amgen (Canada)","funders":"","keywords":"Medicine; Denosumab; Discontinuation; Osteoporosis; Femoral neck; Cost effectiveness; Internal medicine; Teriparatide; Cost-effectiveness analysis; Cohort; Adverse effect; Bone mineral","authors":[{"name":"Diane Chau","is_ca":true},{"name":"D.L. Becker","is_ca":false},{"name":"Megan Coombes","is_ca":false},{"name":"George Ioannidis","is_ca":true},{"name":"Jonathan D. Adachi","is_ca":true},{"name":"Ron Goeree","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.05585751407707094,"gpt":0.3573413247138505,"spread":0.3014838106367796,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002850394,0.00009202216,0.0006356597,0.000156891,0.00001209561,0.000002506102,0.0001702784,0.0001014014,0.0001100749],"category_scores_gemma":[0.0003268177,0.00005727419,0.0000702482,0.0001293202,0.00007329329,0.00006798516,0.00001519804,0.0003016969,9.754774e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00142515,"about_ca_system_score_gemma":0.004917429,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.25545,"about_ca_topic_score_gemma":0.3396921,"domain_scores_codex":[0.9979947,0.0002615603,0.0008866052,0.00006926472,0.0004750543,0.0003127854],"domain_scores_gemma":[0.9980367,0.001052626,0.000309449,0.0001491254,0.00007629087,0.000375789],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002639213,0.002522625,0.9255089,0.0004804694,0.00009786666,0.000138494,0.001991878,0.00005639367,0.0001807997,0.0002012334,0.0002151681,0.06596702],"study_design_scores_gemma":[0.008427892,0.00288236,0.9793776,0.0003569603,0.00004686462,0.0003693824,0.002431287,0.0001575005,0.002316416,0.00003685551,0.003531184,0.00006575239],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9948417,0.002156191,0.000002267403,0.002183154,0.0002339561,0.0004137364,0.00001015457,4.378643e-7,0.0001584056],"genre_scores_gemma":[0.9960073,0.003517813,0.0000581333,0.0002732319,0.0001170325,0.00001179603,0.000003408011,0.000008048304,0.000003218353],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.08424211,"threshold_uncertainty_score":0.8723308,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2337280501","doi":"10.3111/13696998.2016.1164174","title":"The cost-effectiveness of delayed-release dimethyl fumarate for the treatment of relapsing-remitting multiple sclerosis in Canada","year":2016,"lang":"en","type":"article","venue":"Journal of Medical Economics","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"Biogen","keywords":"Dimethyl fumarate; Relapsing remitting; Medicine; Multiple sclerosis; Cost effectiveness; Internal medicine; Oncology; Immunology","authors":[{"name":"Wenqing Su","is_ca":false},{"name":"Colin Vicente","is_ca":false},{"name":"Baris Deniz","is_ca":false},{"name":"Sujata P. Sarda","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.08091913144112999,"gpt":0.3192051370431769,"spread":0.2382860056020469,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003165623,0.0001259599,0.0006094752,0.00006725045,0.0000967082,0.000006660636,0.0002719078,0.00006969858,0.00002127907],"category_scores_gemma":[0.00568841,0.00005353402,0.0002138736,0.00007935752,0.0002709051,0.00005334823,0.00004811663,0.0001721397,4.315462e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001340314,"about_ca_system_score_gemma":0.002211653,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.08760181,"about_ca_topic_score_gemma":0.2561168,"domain_scores_codex":[0.9980938,0.0001594126,0.0009224181,0.0001232111,0.0004128566,0.0002882877],"domain_scores_gemma":[0.983013,0.01569031,0.0005787766,0.0002279442,0.0002661695,0.0002237929],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.006029489,0.0005421258,0.1215269,0.0001702318,0.00134952,0.00001247876,0.0003138927,0.0009345289,0.005372843,0.0001005005,0.0007751029,0.8628724],"study_design_scores_gemma":[0.05787995,0.00505056,0.7925161,0.005604564,0.0005093418,0.00006423115,0.002709534,0.0483521,0.0638819,0.0002728597,0.02279905,0.000359874],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9911569,0.002406385,0.0005598951,0.004717917,0.0003811757,0.0007138982,0.00004406562,0.00000135628,0.00001840644],"genre_scores_gemma":[0.9689439,0.03063407,0.0001514282,0.00004597341,0.0001431321,0.00004864775,7.396898e-7,0.00001456328,0.00001757122],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.8625125,"threshold_uncertainty_score":0.918474,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1967232800","doi":"10.3111/13696998.2010.535577","title":"Changing costs and the impact on RSV prophylaxis","year":2010,"lang":"en","type":"article","venue":"Journal of Medical Economics","topic":"Respiratory viral infections research","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"McMaster Children's Hospital; Sunnybrook Health Science Centre; Health Sciences Centre; University of Toronto","funders":"","keywords":"Medicine; Intensive care medicine; Pre-exposure prophylaxis; Virology; Human immunodeficiency virus (HIV)","authors":[{"name":"Kelly Smart","is_ca":true},{"name":"Bosco Paes","is_ca":true},{"name":"Krista L. Lanctôt","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02339701712570027,"gpt":0.3641934151618424,"spread":0.3407963980361421,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003143608,0.00007779607,0.0002799457,0.0002298134,0.00007341834,0.0000466864,0.0001459128,0.0001371679,0.0004857369],"category_scores_gemma":[0.001852723,0.00003733207,0.0001299615,0.00008923681,0.000315157,0.00007979096,0.00004960599,0.00138485,0.00002403867],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001039503,"about_ca_system_score_gemma":0.0003845551,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001716391,"about_ca_topic_score_gemma":0.000008414471,"domain_scores_codex":[0.9990649,0.00006051174,0.0003353722,0.00007544445,0.0002898054,0.000173991],"domain_scores_gemma":[0.9988811,0.000343933,0.0001518368,0.0001561018,0.00008719228,0.0003798155],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.005627083,0.0006840344,0.02930657,0.00008865525,0.0007523471,0.0004345568,0.0008141607,0.00009826748,0.001915022,0.0143038,0.005816679,0.9401588],"study_design_scores_gemma":[0.1500614,0.05036914,0.3558917,0.002395393,0.0006606622,0.05316975,0.00376604,0.1179141,0.02615553,0.01274719,0.2250071,0.001861954],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9902133,0.00008890875,0.00003535785,0.007319668,0.0003425733,0.000141135,9.435164e-7,0.000003838972,0.001854242],"genre_scores_gemma":[0.9976175,0.0003032912,0.00004651726,0.0009353284,0.001012046,0.00000233451,2.182639e-7,0.00001051917,0.0000722574],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.9382969,"threshold_uncertainty_score":0.6016563,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2108384961","doi":"10.3111/13696998.2011.629015","title":"Savings from the use of a probiotic formula in the prophylaxis of antibiotic-associated diarrhea","year":2011,"lang":"en","type":"article","venue":"Journal of Medical Economics","topic":"Clostridium difficile and Clostridium perfringens research","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"Hôtel-Dieu de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"Microsoft","keywords":"Medicine; Probiotic; Lactobacillus casei; Placebo; Diarrhea; Lactobacillus acidophilus; Context (archaeology); Antibiotic-associated diarrhea; Incidence (geometry); Antibiotics; Internal medicine; Clostridium difficile; Microbiology; Food science; Biology; Fermentation; Alternative medicine","authors":[{"name":"Alvine Adrienne Kamdeu Fansi","is_ca":true},{"name":"Jason R. Guertin","is_ca":true},{"name":"Jacques LeLorier","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.09765356787881542,"gpt":0.2869604975716361,"spread":0.1893069296928206,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001959295,0.0001149481,0.0005463359,0.0001149947,0.00002788879,0.00001535722,0.0005209923,0.0001837814,0.0002054271],"category_scores_gemma":[0.003317356,0.00006012271,0.0002360368,0.0002114353,0.0002768148,0.00009298886,0.00008463874,0.0008114579,0.000003294907],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001142047,"about_ca_system_score_gemma":0.0006853268,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009045465,"about_ca_topic_score_gemma":0.0002300713,"domain_scores_codex":[0.9979182,0.0001490099,0.001026605,0.0001139859,0.0005607886,0.0002313822],"domain_scores_gemma":[0.9978314,0.0009395125,0.0005918611,0.0002944613,0.0001909468,0.0001517978],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.009286565,0.01807139,0.743418,0.001221231,0.003726263,0.001635588,0.04037607,0.0001463278,0.0219532,0.002774107,0.01744344,0.1399478],"study_design_scores_gemma":[0.02098333,0.01174441,0.7585182,0.005565979,0.001042216,0.0009855478,0.006842665,0.008123558,0.1778111,0.001231783,0.006491749,0.0006595226],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9961604,0.000254548,0.00001128915,0.003024399,0.0001177484,0.0002794685,0.00002432548,0.00000213199,0.0001256714],"genre_scores_gemma":[0.9982396,0.00110721,0.000178163,0.0002975745,0.000144519,8.327942e-7,0.000003953516,0.0000130989,0.00001500706],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1558579,"threshold_uncertainty_score":0.3971424,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2919228285","doi":"10.1080/13696998.2019.1590842","title":"Cost-effectiveness of second-line atezolizumab in Canada for advanced non-small cell lung cancer (NSCLC)","year":2019,"lang":"en","type":"article","venue":"Journal of Medical Economics","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"McGill University; Western University; University of Alberta; William Osler Health System; Roche (Canada)","funders":"","keywords":"Atezolizumab; Docetaxel; Medicine; Nivolumab; Oncology; Lung cancer; Cost effectiveness; Clinical trial; Internal medicine; Chemotherapy; Cancer; Immunotherapy; Risk analysis (engineering)","authors":[{"name":"Umang Ondhia","is_ca":true},{"name":"Henry Jacob Conter","is_ca":true},{"name":"Scott Owen","is_ca":true},{"name":"Anna Zhou","is_ca":false},{"name":"Julian Nam","is_ca":true},{"name":"Sumeet Singh","is_ca":false},{"name":"Ahmed Abdulla","is_ca":false},{"name":"Paula Chu","is_ca":false},{"name":"Federico Felizzi","is_ca":false},{"name":"Noman Paracha","is_ca":false},{"name":"Randeep Sangha","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01627561786555592,"gpt":0.2918249683696434,"spread":0.2755493505040875,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001016891,0.0001269603,0.0006886596,0.0001012696,0.00001137971,0.000004639623,0.0001997199,0.0001213333,0.0006998919],"category_scores_gemma":[0.00005819727,0.000105929,0.0001705418,0.00007191711,0.0000333558,0.00006960239,0.00002171989,0.0003016637,5.542178e-7],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001482991,"about_ca_system_score_gemma":0.007726778,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.05542929,"about_ca_topic_score_gemma":0.3044696,"domain_scores_codex":[0.9986449,0.00003585306,0.000767669,0.0001371978,0.0001903925,0.0002240018],"domain_scores_gemma":[0.9986664,0.0003939624,0.0004849074,0.0001386641,0.0001199679,0.0001961028],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.1135269,0.001469013,0.3815358,0.01485412,0.002774268,0.000328469,0.001595815,0.01313403,0.05984981,0.0001365995,0.006045258,0.4047499],"study_design_scores_gemma":[0.2410408,0.006110345,0.3572166,0.01453004,0.0006625064,0.0006516216,0.003787612,0.0594526,0.2374733,0.0001854863,0.07747146,0.001417564],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9947087,0.002002293,0.0002119279,0.0008115357,0.001273019,0.0007304531,0.00004312234,0.000001394934,0.0002175855],"genre_scores_gemma":[0.9967727,0.002047252,0.0002012205,0.0006788218,0.0001637637,0.00001144327,0.000005662936,0.00002120738,0.00009794971],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4033324,"threshold_uncertainty_score":0.9978985,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4402836199","doi":"10.1080/13696998.2024.2407631","title":"Epidemiology and burden of chronic insomnia disorder in Europe: an analysis of the 2020 National Health and Wellness Survey","year":2024,"lang":"en","type":"article","venue":"Journal of Medical Economics","topic":"Sleep and related disorders","field":"Psychology","cited_by":27,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Université Laval","funders":"","keywords":"Medicine; Epidemiology; Insomnia; Chronic insomnia; Psychiatry; Environmental health; Gerontology; Family medicine; Internal medicine; Sleep disorder","authors":[{"name":"François-Xavier Chalet","is_ca":false},{"name":"Emiliano Albanese","is_ca":false},{"name":"Carlos Egea","is_ca":false},{"name":"Jason Ellis","is_ca":false},{"name":"Luigi Ferini‐Strambi","is_ca":false},{"name":"Anna Heidbreder","is_ca":false},{"name":"Damien Léger","is_ca":false},{"name":"Kushal Modi","is_ca":false},{"name":"Charles M. Morin","is_ca":true},{"name":"Abisola Olopoenia","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02693850627665624,"gpt":0.3539406247598802,"spread":0.327002118483224,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004634358,0.00007157369,0.000489049,0.0002473636,0.00002003624,0.000003997335,0.0001990576,0.0001662375,0.0002801926],"category_scores_gemma":[0.0009171428,0.00004732558,0.00007191895,0.0004056294,0.0002709997,0.00005169036,0.00004875567,0.0004159964,0.000001098768],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004684357,"about_ca_system_score_gemma":0.0005712227,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009146728,"about_ca_topic_score_gemma":0.001579899,"domain_scores_codex":[0.9980058,0.0007408674,0.0008694691,0.000141378,0.0001137337,0.0001287521],"domain_scores_gemma":[0.9983315,0.001021733,0.0003723646,0.00009226557,0.00005152054,0.0001305468],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0002916555,0.0005160532,0.7942999,0.000143261,0.005255038,0.00001811321,0.005998517,0.01484084,0.000002025706,0.01992835,0.002941517,0.1557647],"study_design_scores_gemma":[0.002315024,0.0004758977,0.878457,0.0001446578,0.0002691191,0.0001058835,0.001422929,0.1056439,5.950226e-7,0.001792976,0.009246979,0.0001251027],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9625295,0.02580122,0.0001123589,0.01079339,0.0005567275,0.00004677753,0.00002159781,0.000001523392,0.0001368594],"genre_scores_gemma":[0.9869147,0.01254508,0.00001068957,0.0004038735,0.00008647409,5.901834e-7,0.00000771764,0.000007643987,0.00002324704],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1556396,"threshold_uncertainty_score":0.3067913,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2171964208","doi":"10.3111/13696998.2012.667028","title":"Tumor necrosis factor blocker dose escalation among biologic naïve rheumatoid arthritis patients in commercial managed-care plans in the 2 years following therapy initiation","year":2012,"lang":"en","type":"article","venue":"Journal of Medical Economics","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Thomson Reuters (Canada)","funders":"","keywords":"Medicine; Etanercept; Adalimumab; Infliximab; Rheumatoid arthritis; Internal medicine; Tumor necrosis factor alpha; Surgery","authors":[{"name":"Machaon Bonafede","is_ca":true},{"name":"Shravanthi R. Gandra","is_ca":false},{"name":"Kathleen M. Fox","is_ca":false},{"name":"Kathleen Wilson","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0204339455573577,"gpt":0.2750843191235194,"spread":0.2546503735661617,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001255922,0.00012339,0.0003915339,0.0002538568,0.00005663414,0.00005023769,0.0002133904,0.0001462217,0.0001434046],"category_scores_gemma":[0.0004508382,0.00008863707,0.0001623346,0.0001197531,0.00009061203,0.0004086874,0.00003162865,0.0006437255,0.00001033506],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001438571,"about_ca_system_score_gemma":0.00011919,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001122684,"about_ca_topic_score_gemma":0.0005457014,"domain_scores_codex":[0.9982023,0.0002253286,0.0007200369,0.0001026557,0.0004227596,0.0003269117],"domain_scores_gemma":[0.9991013,0.0002654181,0.000258531,0.0001158288,0.00004583465,0.0002130331],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0001937794,0.0002686459,0.8716848,0.00000589005,0.00003791343,0.00004722678,0.004324669,0.000003713495,0.000005044579,0.0000407943,0.0001108049,0.1232767],"study_design_scores_gemma":[0.006482623,0.0003148612,0.9894611,0.000378253,0.000001447466,0.00004273784,0.001555453,0.0001208904,0.00002550123,0.0001034968,0.001425131,0.00008854696],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9960486,0.002207041,0.00001004032,0.0009502516,0.0003972752,0.0002891923,0.00001206452,0.000005599552,0.00007990324],"genre_scores_gemma":[0.9633316,0.03581036,0.00006160364,0.0005868452,0.0001560648,0.00001046654,0.00002830947,0.00001403796,7.561475e-7],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1231882,"threshold_uncertainty_score":0.3614515,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2910482049","doi":"10.1080/13696998.2019.1569446","title":"Cohort versus patient level simulation for the economic evaluation of single versus combination immuno-oncology therapies in metastatic melanoma","year":2019,"lang":"en","type":"article","venue":"Journal of Medical Economics","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Augmentium Pharma Consulting (Canada)","funders":"","keywords":"Medicine; Metastatic melanoma; Cohort; Oncology; Internal medicine; Melanoma; Overall survival; Cancer","authors":[{"name":"Edward Gibson","is_ca":false},{"name":"Najida Begum","is_ca":false},{"name":"Ian Koblbauer","is_ca":false},{"name":"George Dranitsaris","is_ca":true},{"name":"Danny Liew","is_ca":false},{"name":"Phil McEwan","is_ca":false},{"name":"Yong Yuan","is_ca":false},{"name":"A. Juarez-Garcia","is_ca":false},{"name":"David Tyas","is_ca":false},{"name":"Clive Pritchard","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1416524573366851,"gpt":0.4049893729289035,"spread":0.2633369155922184,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.005591569,0.00009822755,0.0004635036,0.0001991524,0.00002557373,0.00001482938,0.0001866755,0.0001234241,0.001823508],"category_scores_gemma":[0.0009531023,0.00007334269,0.0001724911,0.00005346624,0.00009444278,0.0001315392,0.00003117786,0.0002386387,0.000008163855],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001916147,"about_ca_system_score_gemma":0.001464842,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00005110351,"about_ca_topic_score_gemma":0.000146013,"domain_scores_codex":[0.9980988,0.0002054552,0.0008943394,0.0001213111,0.0005207738,0.0001593276],"domain_scores_gemma":[0.9953254,0.003435483,0.0006430448,0.0001923939,0.0003203632,0.00008330319],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","study_design_scores_codex":[0.03913254,0.0008508342,0.004664923,0.00008334165,0.002282773,0.000004961229,0.002295726,0.1276625,0.002649857,0.001114101,0.0002011393,0.8190573],"study_design_scores_gemma":[0.08436578,0.01079635,0.01396263,0.00009909633,0.0006022279,0.0000356017,0.00291834,0.8733308,0.001706231,0.0009031456,0.01112914,0.0001506889],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9936266,0.0005711721,0.0002369705,0.002161089,0.001815144,0.001077599,0.000007524388,0.000002111054,0.0005017773],"genre_scores_gemma":[0.9990137,0.0004973988,0.0002140963,0.00006672275,0.0001292592,0.00002127328,0.00001392498,0.00001674878,0.00002687423],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.8189066,"threshold_uncertainty_score":0.9990889,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4360989335","doi":"10.1080/13696998.2023.2195753","title":"A systematic review of SF-6D health state valuation studies","year":2023,"lang":"en","type":"review","venue":"Journal of Medical Economics","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":24,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Université de Montréal","funders":"Fonds de Recherche du Québec - Santé","keywords":"Checklist; Medicine; Valuation (finance); Preference; Dimension (graph theory); Health economics; Quality-adjusted life year; Population; Quality of life (healthcare); Scopus; EQ-5D; Systematic review; MEDLINE; Actuarial science; Health related quality of life; Statistics; Psychology; Public health; Environmental health; Cost effectiveness; Economics","authors":[{"name":"Liang Wang","is_ca":true},{"name":"Thomas G. Poder","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.7462706308130562,"gpt":0.5826734476324421,"spread":0.1635971831806141,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad","insufficient_payload"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.1510129,0.0005608051,0.01822946,0.00118003,0.00010952,0.00005697777,0.001397815,0.0004593502,0.0002105781],"category_scores_gemma":[0.05723066,0.0005262571,0.001735621,0.0004575428,0.000170894,0.0004070574,0.000205456,0.0009736207,0.001156116],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002755644,"about_ca_system_score_gemma":0.00497201,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00007337889,"about_ca_topic_score_gemma":0.00004730741,"domain_scores_codex":[0.9599055,0.002329432,0.03606997,0.0005777029,0.0005477993,0.0005695715],"domain_scores_gemma":[0.939445,0.006533753,0.05211383,0.0008553158,0.0003827854,0.000669356],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","study_design_scores_codex":[0.000002138421,0.00006298501,0.000001897928,0.9576426,0.001951883,0.00000618205,0.0004070885,0.000009572756,1.289167e-10,0.006855074,0.02546282,0.007597727],"study_design_scores_gemma":[0.000373679,0.0001643269,0.000001008735,0.7289743,0.0004370963,0.000160173,0.0003013237,0.0001638343,6.525924e-9,0.005201587,0.2639104,0.0003123023],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000007164448,0.9726024,0.000586247,0.02157302,0.002346211,0.002399852,0.0003945997,0.00002275313,0.0000677333],"genre_scores_gemma":[4.601236e-7,0.98996,0.0006408194,0.008120861,0.0007209224,0.0001316688,0.00004590331,0.0001144064,0.0002649414],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.2384476,"threshold_uncertainty_score":0.9997189,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2252889185","doi":"10.3111/13696998.2015.1100115","title":"Pharmacoeconomics of long-acting atypical antipsychotics for acutely relapsed chronic schizophrenia in Finland","year":2015,"lang":"en","type":"article","venue":"Journal of Medical Economics","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Risperidone; Aripiprazole; Tolerability; Paliperidone; Olanzapine; Internal medicine; Schizophrenia (object-oriented programming); Adverse effect; Psychiatry","authors":[{"name":"Thomas R. Einarson","is_ca":true},{"name":"Hanna Pudas","is_ca":false},{"name":"Pushpendra Goswami","is_ca":false},{"name":"K. Van Impe","is_ca":false},{"name":"Basil G. Bereza","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.05978874739694853,"gpt":0.3764482381906464,"spread":0.3166594907936979,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001772005,0.0001556895,0.0007338215,0.0002574752,0.00002197298,0.00001974982,0.0002670293,0.0002160274,0.0001341281],"category_scores_gemma":[0.0009636341,0.0001272471,0.000244598,0.00008642412,0.0001196687,0.0001451863,0.00005094894,0.0006191191,0.00001447663],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000548484,"about_ca_system_score_gemma":0.003178008,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000005807428,"about_ca_topic_score_gemma":0.00009953872,"domain_scores_codex":[0.9980537,0.00004852779,0.00108397,0.0001740823,0.0003120738,0.0003276286],"domain_scores_gemma":[0.9978872,0.0004073792,0.0004914227,0.0001766105,0.0001690423,0.0008683405],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.4018437,0.002992359,0.09573212,0.0006415495,0.002225089,0.001519606,0.0005189491,0.001492924,0.0001827755,0.003096491,0.01247092,0.4772836],"study_design_scores_gemma":[0.504451,0.02366938,0.2156439,0.00329083,0.001413545,0.008084528,0.000997833,0.183874,0.01241895,0.01347434,0.03133541,0.001346223],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9902251,0.001047059,0.0009327366,0.006754297,0.0006542468,0.000285835,0.00001376538,0.000004360358,0.00008255008],"genre_scores_gemma":[0.9883433,0.002195707,0.008163552,0.0002132909,0.001008877,0.000005438191,0.000009208543,0.00002746217,0.00003318483],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4759373,"threshold_uncertainty_score":0.5637649,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2168221836","doi":"10.3111/13696998.2013.779277","title":"Medical resource use and costs associated with chylomicronemia","year":2013,"lang":"en","type":"article","venue":"Journal of Medical Economics","topic":"Lipid metabolism and disorders","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Acute pancreatitis; Hypertriglyceridemia; Pancreatitis; Internal medicine; Medical costs; Demographics; Gastroenterology; Pediatrics; Triglyceride; Cholesterol; Demography; Health care","authors":[{"name":"Daniel Gaudet","is_ca":true},{"name":"James Signorovitch","is_ca":false},{"name":"Elyse Swallow","is_ca":false},{"name":"Liangyi Fan","is_ca":false},{"name":"Karine Tremblay","is_ca":true},{"name":"Diane Brisson","is_ca":true},{"name":"Charles D. Meyers","is_ca":false},{"name":"Jean-Bernard Gruenberger","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01033664638922221,"gpt":0.2274725491197174,"spread":0.2171359027304952,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001204211,0.0001348578,0.0005476771,0.0001090287,0.00003879026,0.0000606375,0.0001792217,0.0003235235,0.001212458],"category_scores_gemma":[0.004882923,0.00008979216,0.00008138413,0.00006406628,0.0002711482,0.0002713268,0.00006285509,0.0006627775,0.00001848349],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00009646705,"about_ca_system_score_gemma":0.0007404535,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00007523015,"about_ca_topic_score_gemma":0.00004260439,"domain_scores_codex":[0.9983707,0.00006323305,0.0005980369,0.0001389274,0.0005840646,0.000245022],"domain_scores_gemma":[0.9976648,0.0004381746,0.0003326277,0.0001422481,0.0001855069,0.001236604],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00162418,0.001740076,0.3493927,0.0001412077,0.0018932,0.0008550236,0.001154028,0.00001897539,0.000227602,0.002751906,0.3307103,0.3094909],"study_design_scores_gemma":[0.04812511,0.002078983,0.6022875,0.00257612,0.0008769897,0.007379633,0.002403971,0.006388781,0.0003061692,0.0004701977,0.3262639,0.0008426263],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9745513,0.000520637,0.00006783802,0.02376957,0.0001923387,0.0001233974,0.000002481294,0.00001058541,0.0007619141],"genre_scores_gemma":[0.9790203,0.002938617,0.0004989462,0.0164308,0.0007948246,0.000003106251,0.000009517671,0.00003531393,0.0002685636],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3086482,"threshold_uncertainty_score":0.9997005,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2740431138","doi":"10.1080/13696998.2017.1363050","title":"Cost-effectiveness of 3-month paliperidone therapy for chronic schizophrenia in the Netherlands","year":2017,"lang":"en","type":"article","venue":"Journal of Medical Economics","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Paliperidone Palmitate; Paliperidone; Risperidone; Cost effectiveness; Olanzapine; Quality-adjusted life year; Emergency medicine; Schizophrenia (object-oriented programming); Psychiatry","authors":[{"name":"Thomas R. Einarson","is_ca":true},{"name":"Basil G. Bereza","is_ca":true},{"name":"Fadi Tedouri","is_ca":false},{"name":"K. Van Impe","is_ca":false},{"name":"Tom Denee","is_ca":false},{"name":"Pieter J. T. Dries","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0715635955191591,"gpt":0.3826967046580764,"spread":0.3111331091389173,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003432466,0.0001065388,0.000496032,0.00009078222,0.00008135525,0.00003991275,0.0005202617,0.0001209531,0.00007831559],"category_scores_gemma":[0.0007040059,0.00005880701,0.0002236725,0.00002766712,0.0001910796,0.00009358188,0.0000319852,0.0003597148,0.000001916648],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001781706,"about_ca_system_score_gemma":0.001233887,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004063599,"about_ca_topic_score_gemma":0.0001963626,"domain_scores_codex":[0.9988096,0.0001162831,0.0004381643,0.0001073983,0.0003218609,0.0002066922],"domain_scores_gemma":[0.9982926,0.0006768618,0.0003760549,0.0003557773,0.00009187042,0.0002068685],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.1208523,0.001955485,0.05279101,0.0003645307,0.001155585,0.0003918474,0.0004319807,0.0000959997,0.000346778,0.005283274,0.0009379513,0.8153933],"study_design_scores_gemma":[0.1197276,0.009643949,0.8435683,0.001151524,0.000131758,0.0007065941,0.0002222768,0.003821788,0.004237295,0.006582871,0.01000844,0.0001976356],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9884544,0.001696521,0.0001689003,0.008668249,0.000230034,0.0006617473,0.000009650898,0.000001700032,0.0001088087],"genre_scores_gemma":[0.993795,0.004957335,0.0004028496,0.0001071489,0.0006679072,0.0000441456,0.000004558142,0.0000128064,0.000008238581],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.8151957,"threshold_uncertainty_score":0.239808,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2292517844","doi":"10.3111/13696998.2015.1106546","title":"Cost-effectiveness of daclatasvir plus sofosbuvir-based regimen for treatment of hepatitis C virus genotype 3 infection in Canada","year":2015,"lang":"en","type":"article","venue":"Journal of Medical Economics","topic":"Hepatitis C virus research","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"McMaster University","funders":"","keywords":"Sofosbuvir; Medicine; Daclatasvir; Internal medicine; Regimen; Ribavirin; Quality-adjusted life year; Cost effectiveness; Hepatitis C; Hepatitis C virus; Gastroenterology; Virology; Virus","authors":[{"name":"Andriy Moshyk","is_ca":false},{"name":"Myriam Martel","is_ca":false},{"name":"Amir Abbas Tahami Monfared","is_ca":false},{"name":"Ron Goeree","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.103942481667577,"gpt":0.3671978009279744,"spread":0.2632553192603975,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001769631,0.0001163545,0.0008054558,0.000223968,0.00001329685,0.000004719158,0.0001245795,0.0001393316,0.00007972642],"category_scores_gemma":[0.001205883,0.00009867465,0.0001223498,0.0001087629,0.00008495446,0.00008081305,0.00002012925,0.0001598352,0.000001440889],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.004772352,"about_ca_system_score_gemma":0.01653652,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.7307118,"about_ca_topic_score_gemma":0.7818226,"domain_scores_codex":[0.9981754,0.0001712025,0.0008392827,0.0001230516,0.0004777263,0.0002133797],"domain_scores_gemma":[0.9979202,0.0006769035,0.0004308437,0.0001781843,0.0003216361,0.0004722684],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.009098963,0.001143498,0.8221652,0.0007787516,0.000607846,0.0003338711,0.0003353467,0.009399346,0.0005043409,0.0001859937,0.001978135,0.1534687],"study_design_scores_gemma":[0.1013207,0.02303286,0.4913841,0.002422612,0.0005412311,0.0002883751,0.00023979,0.1731808,0.09510227,0.0008635846,0.1109624,0.0006613085],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9965875,0.0002875553,0.001324212,0.0005779218,0.0003404044,0.0006412932,0.00008334972,0.000001991674,0.0001557927],"genre_scores_gemma":[0.9967996,0.002418118,0.0004620999,0.00008997254,0.0001448517,0.00003012969,0.00002589669,0.00001963983,0.000009676157],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3307811,"threshold_uncertainty_score":0.9990482,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2059760712","doi":"10.3111/13696998.2015.1033423","title":"Costing bias in economic evaluations","year":2015,"lang":"en","type":"editorial","venue":"Journal of Medical Economics","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":23,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Université de Montréal; Université du Québec à Montréal","funders":"","keywords":"Activity-based costing; Health care; Risk analysis (engineering); Health economics; Process (computing); Key (lock); Psychological intervention; Target costing; Medicine; Operations management; Actuarial science; Computer science; Business; Economics; Nursing; Accounting; Computer security","authors":[{"name":"Gabriel Tremblay","is_ca":false},{"name":"Mark Charny","is_ca":false},{"name":"L. Martin Cloutier","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.4713449133992674,"gpt":0.5149067998982277,"spread":0.04356188649896031,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaresearch","research_integrity","insufficient_payload"],"category_scores_codex":[0.1295798,0.0005629602,0.004127107,0.001664746,0.0001135142,0.0002680547,0.001947075,0.0023127,0.001914846],"category_scores_gemma":[0.1024601,0.0007036804,0.0005732524,0.0001797642,0.0002029516,0.0009847704,0.000250282,0.002889279,0.002599166],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.007662731,"about_ca_system_score_gemma":0.01172248,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001139121,"about_ca_topic_score_gemma":0.00175393,"domain_scores_codex":[0.9796199,0.0009023134,0.01712118,0.0008258164,0.000732886,0.0007979135],"domain_scores_gemma":[0.9691975,0.01071335,0.01755447,0.0008459328,0.0004437703,0.001245003],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00004002401,0.0001172913,0.0009814282,0.0002077925,0.0001859493,0.00001726784,0.0005666804,0.002046599,1.856568e-8,0.006434422,0.9887415,0.0006610129],"study_design_scores_gemma":[0.003314327,0.0001987065,0.0001405147,0.0007225942,0.00003572095,0.00004074683,0.0005232113,0.01224748,2.874595e-7,0.02262355,0.9595554,0.0005975002],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"editorial","genre_gemma":"editorial","genre_scores_codex":[0.01362036,0.008506838,0.0005179811,0.04188276,0.9275298,0.0006909419,0.001206017,0.00003190999,0.006013412],"genre_scores_gemma":[0.002349569,0.008818499,0.002107244,0.004098075,0.9811004,0.00006246391,0.0003036454,0.0002385442,0.0009215918],"genre_candidate":"editorial","genre_consensus":"editorial","teacher_disagreement_score":0.05357059,"threshold_uncertainty_score":0.9995415,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2050660689","doi":"10.3111/13696998.2014.903256","title":"Is transcatheter aortic valve implantation (TAVI) a cost-effective treatment in patients who are ineligible for surgical aortic valve replacement? A systematic review of economic evaluations","year":2014,"lang":"en","type":"review","venue":"Journal of Medical Economics","topic":"Cardiac Valve Diseases and Treatments","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Reimbursement; Economic evaluation; Purchasing power parity; MEDLINE; Health technology; Meta-analysis; Aortic valve replacement; Health care; Checklist; Cost effectiveness; Actuarial science; Finance; Stenosis; Internal medicine; Economics; Exchange rate","authors":[{"name":"James Eaton","is_ca":false},{"name":"Stuart Mealing","is_ca":false},{"name":"Juliette C. Thompson","is_ca":false},{"name":"Neil Moat","is_ca":false},{"name":"A. Pieter Kappetein","is_ca":false},{"name":"Nicolò Piazza","is_ca":true},{"name":"Rachele Busca","is_ca":false},{"name":"Ruben L.J. Osnabrugge","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0349624507930824,"gpt":0.4217727569544759,"spread":0.3868103061613935,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.001897247,0.000523204,0.006630389,0.0004216181,0.00003727097,0.00002533177,0.0002142132,0.0003468842,0.0001497663],"category_scores_gemma":[0.0005703863,0.0003632187,0.01024129,0.0001093949,0.00005681684,0.0001018891,0.00002765384,0.0002839307,0.00002802196],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002313085,"about_ca_system_score_gemma":0.001393159,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0000201762,"about_ca_topic_score_gemma":0.000005636251,"domain_scores_codex":[0.9945797,0.000450359,0.003745927,0.0004142656,0.0004818307,0.0003279164],"domain_scores_gemma":[0.9940779,0.001136665,0.003569324,0.0004660599,0.0002582067,0.0004918034],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","study_design_scores_codex":[0.0004130433,0.001538257,0.003429656,0.8208004,0.01567685,0.000005132681,0.0001480373,0.000007393672,2.498914e-9,0.00002968247,0.000303075,0.1576485],"study_design_scores_gemma":[0.0180761,0.003100668,0.001597189,0.8742276,0.08647548,0.0002255603,0.000043878,0.0004094361,6.370798e-7,0.00007934269,0.01532874,0.0004353047],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.01057395,0.9742833,0.00004136052,0.000166325,0.0004445918,0.01384343,0.0006020356,0.000005819842,0.00003919108],"genre_scores_gemma":[0.002360966,0.9947001,0.00002460798,0.0002369997,0.0002224985,0.001972648,0.0003922317,0.00006470484,0.00002525644],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.1572132,"threshold_uncertainty_score":0.999882,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1992802587","doi":"10.3111/13696998.2014.897626","title":"Economic evaluation of BST-CarGel as an adjunct to microfracture vs microfracture alone in knee cartilage surgery","year":2014,"lang":"en","type":"article","venue":"Journal of Medical Economics","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Queen Elizabeth II Health Sciences Centre","funders":"","keywords":"Medicine; Knee replacement; Surgery; Orthopedic surgery; Referral; Cartilage damage; Osteoarthritis; Articular cartilage","authors":[{"name":"William D. Stanish","is_ca":true},{"name":"Mats Brittberg","is_ca":false},{"name":"Matthias Steinwachs","is_ca":false},{"name":"Lydia Crowe","is_ca":false},{"name":"D.J.S. Castelo","is_ca":false},{"name":"Alberto Restrepo","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01677445460773767,"gpt":0.2904359798159504,"spread":0.2736615252082127,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.004358446,0.000216933,0.001018185,0.0004142578,0.00002656115,0.00002178151,0.0001811992,0.0003799726,0.0009165232],"category_scores_gemma":[0.0008044255,0.0001862687,0.000275426,0.0000667061,0.0000511661,0.0002298888,0.000037672,0.0004421916,0.00006031163],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004212969,"about_ca_system_score_gemma":0.001326124,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00008940555,"about_ca_topic_score_gemma":0.0006098832,"domain_scores_codex":[0.9976699,0.0001857117,0.001145121,0.000247053,0.0004610792,0.0002910893],"domain_scores_gemma":[0.9980102,0.0002640501,0.0006004053,0.0002997342,0.0001736875,0.0006519383],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.008132176,0.002505787,0.07904146,0.0003394955,0.000519902,0.0004722069,0.003537953,0.001342925,0.03728697,0.001184942,0.01753133,0.8481048],"study_design_scores_gemma":[0.1090384,0.03145229,0.1209598,0.00630168,0.00411531,0.007423282,0.003776893,0.01062502,0.5201267,0.01635378,0.1670887,0.002738052],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9930082,0.0006087011,0.00005289369,0.004453066,0.001158902,0.000331253,0.00001152893,0.000006036433,0.000369428],"genre_scores_gemma":[0.9956734,0.0003199183,0.0004539153,0.002421323,0.00101134,0.000007072641,0.00003511648,0.00003410587,0.00004380181],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.8453668,"threshold_uncertainty_score":0.9999968,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1979583846","doi":"10.3111/13696998.2014.950669","title":"Healthcare costs for Crohn’s disease patients treated with infliximab: a propensity weighted comparison of the effects of treatment adherence","year":2014,"lang":"en","type":"article","venue":"Journal of Medical Economics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":23,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Robarts Clinical Trials; Western University","funders":"","keywords":"Medicine; Infliximab; Propensity score matching; Internal medicine; Pharmacy; Rheumatoid arthritis; Crohn's disease; Surgery; Disease; Family medicine","authors":[{"name":"Brian G. Feagan","is_ca":true},{"name":"Chris M Kozma","is_ca":false},{"name":"Terra Slaton","is_ca":false},{"name":"William H. Olson","is_ca":false},{"name":"George J. Wan","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.00986530010196417,"gpt":0.2562391222970435,"spread":0.2463738221950793,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001907434,0.0001131341,0.0003103877,0.00002292468,0.00003538375,0.000005618265,0.0002267493,0.00009538067,0.000003731813],"category_scores_gemma":[0.0003748776,0.00006635109,0.0001437205,0.00002133681,0.0001294628,0.000005712503,0.00004285409,0.00007064397,2.816163e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00008832962,"about_ca_system_score_gemma":0.000621787,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002118157,"about_ca_topic_score_gemma":0.0001011569,"domain_scores_codex":[0.9990405,0.0001151475,0.0004624967,0.00011648,0.0001437354,0.0001216725],"domain_scores_gemma":[0.9985238,0.00005565421,0.0006780286,0.0002145246,0.0002506772,0.0002772889],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.004840798,0.0007482329,0.9813552,0.0003927895,0.0002166493,0.000009142018,0.0000821551,0.00005419956,0.000324174,0.0001213878,0.0003605045,0.01149479],"study_design_scores_gemma":[0.00851069,0.00441166,0.9689516,0.0003898409,0.0001939148,0.0000038576,0.00002214836,0.001824221,0.01424687,0.00004351672,0.001259643,0.0001420047],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9989959,0.0001059641,0.00007990457,0.0001878498,0.0001280601,0.0004591042,0.00003126152,0.000001194616,0.00001076587],"genre_scores_gemma":[0.999575,0.00007238898,0.00008707531,0.0001302975,0.00008185678,0.00001285889,0.00001646284,0.00001104591,0.0000130598],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01392269,"threshold_uncertainty_score":0.2705719,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2106512674","doi":"10.3111/13696990701438629","title":"Cost effectiveness of rimonabant use in patients at increased cardiometabolic risk: estimates from a Markov model","year":2007,"lang":"en","type":"article","venue":"Journal of Medical Economics","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University","funders":"Johns Hopkins University; Sanofi","keywords":"Medicine; Rimonabant; Overweight; Quality-adjusted life year; Cost effectiveness; Obesity; Internal medicine; Risk analysis (engineering)","authors":[{"name":"J. Jaime","is_ca":true},{"name":"Ipek Özer Stillman","is_ca":false},{"name":"A Danel","is_ca":false},{"name":"Denis Getsios","is_ca":false},{"name":"P McEwan","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01895269973768576,"gpt":0.2711988113097658,"spread":0.25224611157208,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001817447,0.0001392519,0.000766677,0.0003063364,0.00001759363,0.00001029736,0.0001352794,0.0001214481,0.00004931716],"category_scores_gemma":[0.0006237432,0.0001098422,0.0001907663,0.00008682058,0.00007187927,0.0001368543,0.00009797334,0.000217404,0.000003627424],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000316952,"about_ca_system_score_gemma":0.00011926,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002298283,"about_ca_topic_score_gemma":0.00005635939,"domain_scores_codex":[0.9985364,0.00006538934,0.0007101918,0.0001390073,0.0003317081,0.0002172658],"domain_scores_gemma":[0.9982409,0.0007429911,0.0004467532,0.0001667681,0.00006331094,0.0003392494],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002318488,0.0007594267,0.9646004,0.00006083642,0.0006270522,0.00006636236,0.00005310699,0.0006343874,0.00003604591,0.00003572683,0.00009522607,0.03071295],"study_design_scores_gemma":[0.01159049,0.0002982499,0.9709169,0.0003268322,0.0004886222,0.000003893524,0.00002329915,0.01485081,0.001018954,0.0001828696,0.0002093316,0.00008977365],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9982004,0.0002117033,0.0007999507,0.0000487331,0.0001993206,0.0003023984,0.000036844,0.000004448292,0.0001962092],"genre_scores_gemma":[0.9966826,0.0006236213,0.002455895,0.0001003483,0.00007021211,0.000003391071,0.00003630734,0.00001697563,0.00001068531],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03062317,"threshold_uncertainty_score":0.4479233,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2097511134","doi":"10.3111/13696998.2013.857676","title":"Understanding the economic, daily functioning, and diabetes management burden of non-severe nocturnal hypoglycemic events in Canada: differences between type 1 and type 2","year":2013,"lang":"en","type":"article","venue":"Journal of Medical Economics","topic":"Diabetes Management and Research","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Medicine; Type 2 diabetes; Nocturnal; Diabetes mellitus; Diabetes management; Type 1 diabetes; Pediatrics; Gerontology; Intensive care medicine; Internal medicine; Endocrinology","authors":[{"name":"Meryl Brod","is_ca":false},{"name":"Michael Lyng Wolden","is_ca":false},{"name":"Danielle Groleau","is_ca":false},{"name":"Donald M. Bushnell","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03986739751327643,"gpt":0.2527847276198688,"spread":0.2129173301065923,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006704184,0.00009406999,0.0003554817,0.0001427787,0.00004194643,0.00002410839,0.0001813383,0.00006054992,0.0003034899],"category_scores_gemma":[0.00007034362,0.00006084727,0.00002775006,0.00006402127,0.0001034328,0.0001140006,0.0001349646,0.0003187449,0.00000336161],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004577032,"about_ca_system_score_gemma":0.000542296,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.009416834,"about_ca_topic_score_gemma":0.007121803,"domain_scores_codex":[0.9989665,0.00003047442,0.0004600961,0.0001068521,0.0002353262,0.0002007428],"domain_scores_gemma":[0.9992231,0.0002117566,0.0002284809,0.00008969477,0.00004066714,0.0002063464],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00006953721,0.00001203691,0.9799554,0.0001333701,0.0004084606,0.000006817123,0.00009505759,0.0001079545,0.000006410996,0.0001433232,0.00241129,0.01665033],"study_design_scores_gemma":[0.002379359,0.0003568064,0.9820659,0.0003629808,0.0001242405,0.00001076384,0.002052466,0.01005076,0.000007916477,0.001746836,0.0007392499,0.0001026723],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9945384,0.0002793152,0.00001888348,0.00392371,0.0003096306,0.0001607671,0.000001217297,0.000001088093,0.0007670083],"genre_scores_gemma":[0.9977299,0.001660327,0.00005046296,0.0001342137,0.0002176185,0.000001219967,0.000001695485,0.000008203408,0.0001963759],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01654766,"threshold_uncertainty_score":0.9971796,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4384664050","doi":"10.1080/13696998.2023.2237336","title":"Early access for innovative oncology medicines: a different story in each nation","year":2023,"lang":"en","type":"review","venue":"Journal of Medical Economics","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":22,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":true},"ca_institutions":"ABB (Canada)","funders":"AbbVie Canada","keywords":"Medicine; Internal medicine; Oncology; Family medicine","authors":[{"name":"Tara Cowling","is_ca":false},{"name":"Ransi Nayakarathna","is_ca":false},{"name":"Allison Wills","is_ca":false},{"name":"Dipti Tankala","is_ca":true},{"name":"Nancy Paul Roc","is_ca":true},{"name":"Stéphane Barakat","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.7144830394150865,"gpt":0.5836889240515664,"spread":0.1307941153635201,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.05289139,0.0004757846,0.007051246,0.002519185,0.00009670194,0.0001078488,0.001613231,0.00131026,0.0002412118],"category_scores_gemma":[0.02438816,0.0004729517,0.0006591236,0.0005391311,0.0001636669,0.0006213717,0.0002000951,0.001775098,0.0002528079],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.004832007,"about_ca_system_score_gemma":0.00386338,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001369892,"about_ca_topic_score_gemma":0.000369248,"domain_scores_codex":[0.9839024,0.0008416469,0.01382101,0.0006190493,0.0002527147,0.0005631872],"domain_scores_gemma":[0.9738437,0.009369655,0.01566084,0.0003937355,0.0002527295,0.000479336],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001317862,0.001168542,0.001011517,0.05276794,0.002577629,0.00007016551,0.004434579,0.00009125303,9.716645e-9,0.1148667,0.1618588,0.6610211],"study_design_scores_gemma":[0.001942582,0.0003495712,0.0002717481,0.007391197,0.00007217676,0.00005094291,0.0003651792,0.00068858,1.86749e-8,0.008498436,0.979977,0.0003925835],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.002058469,0.9461581,0.002226114,0.04021012,0.006457121,0.002025421,0.000395592,0.00002654426,0.0004425925],"genre_scores_gemma":[0.0000633353,0.9918748,0.0002781769,0.003886233,0.003203788,0.000287367,0.00009517781,0.0001171305,0.0001940402],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.8181182,"threshold_uncertainty_score":0.9999862,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null}]}